symbol,period,item_code,item_name_tr,item_name_en,value
BIOEN,2020/12,1A,Dönen Varlıklar,CURRENT ASSETS,31865598.0
BIOEN,2020/12,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,13697569.0
BIOEN,2020/12,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2020/12,1AC,Ticari Alacaklar,Short-Term Trade Receivables,4063338.0
BIOEN,2020/12,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2020/12,1AE,Diğer Alacaklar,Short-Term Other Receivables,1126419.0
BIOEN,2020/12,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2020/12,1AF,Stoklar,Inventories,594223.0
BIOEN,2020/12,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2020/12,1AH,Diğer Dönen Varlıklar,Other Current Assets,12384049.0
BIOEN,2020/12,1AI,(Ara Toplam),(Subtotal),31865598.0
BIOEN,2020/12,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2020/12,1AK,Duran Varlıklar,LONG TERM ASSETS,77751397.0
BIOEN,2020/12,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2020/12,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2020/12,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2020/12,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2020/12,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2020/12,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,3404231.0
BIOEN,2020/12,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2020/12,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,442888.0
BIOEN,2020/12,1BFA,Stoklar,Stoklar,0.0
BIOEN,2020/12,1BFAA,Kullanım Hakkı Varlıkları,nan,5037593.0
BIOEN,2020/12,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,58670887.0
BIOEN,2020/12,1BGA,Şerefiye,Goodwill,878819.0
BIOEN,2020/12,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,7854049.0
BIOEN,2020/12,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2020/12,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,1462929.0
BIOEN,2020/12,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,109616994.0
BIOEN,2020/12,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2020/12,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,29797658.0
BIOEN,2020/12,2AA,Finansal Borçlar,Short-Term Financial Loans,11550373.0
BIOEN,2020/12,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2020/12,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,11897138.0
BIOEN,2020/12,2AAGAB,Diğer Borçlar,Other Short-Term Loans,3644143.0
BIOEN,2020/12,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2020/12,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2020/12,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2020/12,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,1030871.0
BIOEN,2020/12,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),677050.0
BIOEN,2020/12,2AAGE,Borç Karşılıkları,Short-Term Provisions,631438.0
BIOEN,2020/12,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,366644.0
BIOEN,2020/12,2AAGG,(Ara Toplam),(Subtotal),29797658.0
BIOEN,2020/12,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2020/12,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,52913184.0
BIOEN,2020/12,2BA,Finansal Borçlar,Long-Term Financial Loans,49565554.0
BIOEN,2020/12,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2020/12,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2020/12,2BBB,Diğer Borçlar,Other Long-Term Loans,713451.0
BIOEN,2020/12,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2020/12,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2020/12,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2020/12,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,334217.0
BIOEN,2020/12,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,102807.0
BIOEN,2020/12,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2020/12,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,2197156.0
BIOEN,2020/12,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2020/12,2N,Özkaynaklar,SHAREHOLDERS EQUITY,26906152.0
BIOEN,2020/12,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,26929509.0
BIOEN,2020/12,2OA,Ödenmiş Sermaye,Share Capital,17221198.0
BIOEN,2020/12,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2020/12,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,0.0
BIOEN,2020/12,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2020/12,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2020/12,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2020/12,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),775220.0
BIOEN,2020/12,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),6790845.0
BIOEN,2020/12,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,2142246.0
BIOEN,2020/12,2ODA,Azınlık Payları,Minority Interests,-23357.0
BIOEN,2020/12,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,109616994.0
BIOEN,2020/12,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2020/12,3C,Satış Gelirleri,Net Sales,34905687.0
BIOEN,2020/12,3CA,Satışların Maliyeti (-),Cost Of Sales,-25259896.0
BIOEN,2020/12,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2020/12,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,9645791.0
BIOEN,2020/12,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2020/12,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2020/12,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2020/12,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2020/12,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2020/12,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),9645791.0
BIOEN,2020/12,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-158908.0
BIOEN,2020/12,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-2962755.0
BIOEN,2020/12,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2020/12,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,9549778.0
BIOEN,2020/12,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-6219016.0
BIOEN,2020/12,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2020/12,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,9854890.0
BIOEN,2020/12,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,6524128.0
BIOEN,2020/12,3HA,Yatırım Faaliyetlerinden Gelirler,nan,3862656.0
BIOEN,2020/12,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-97471.0
BIOEN,2020/12,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2020/12,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,1585252.0
BIOEN,2020/12,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,15205327.0
BIOEN,2020/12,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),2314073.0
BIOEN,2020/12,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-9064243.0
BIOEN,2020/12,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,3765185.0
BIOEN,2020/12,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,8455157.0
BIOEN,2020/12,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-1351485.0
BIOEN,2020/12,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-1047090.0
BIOEN,2020/12,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-304396.0
BIOEN,2020/12,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2020/12,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,7103672.0
BIOEN,2020/12,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2020/12,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2020/12,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,7103672.0
BIOEN,2020/12,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2020/12,3LB,Azınlık Payları,Minority Interests,-78682.0
BIOEN,2020/12,3Z,Ana Ortaklık Payları,Parent Shares,7182354.0
BIOEN,2020/12,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2020/12,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2020/12,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2020/12,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2020/12,4B,Amortisman Giderleri,Depreciation & Amortization,3189781.0
BIOEN,2020/12,4BA,Kıdem Tazminatı,Severance Payments,53934.0
BIOEN,2020/12,4BB,Finansman Giderleri,Financial Expenses,-9064243.0
BIOEN,2020/12,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2020/12,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2020/12,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-41210790.0
BIOEN,2020/12,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-48363285.0
BIOEN,2020/12,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-41210790.0
BIOEN,2020/12,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,7538291.0
BIOEN,2020/12,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,7103672.0
BIOEN,2020/12,4CAA,Düzeltmeler:,Adjustments:,9966120.0
BIOEN,2020/12,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,3189781.0
BIOEN,2020/12,4CAC,Karşılıklardaki Değişim,Change in Provisions,641250.0
BIOEN,2020/12,4CAD,Diğer Gelir/ Gider,Other Income / Expense,6135089.0
BIOEN,2020/12,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),17069792.0
BIOEN,2020/12,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-9015881.0
BIOEN,2020/12,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),8053911.0
BIOEN,2020/12,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-515620.0
BIOEN,2020/12,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-39632443.0
BIOEN,2020/12,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,-7439575.0
BIOEN,2020/12,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-47072018.0
BIOEN,2020/12,4CB,Serbest Nakit Akım,Free Cash Flow,-39533727.0
BIOEN,2020/12,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,41064288.0
BIOEN,2020/12,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2020/12,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2020/12,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,10346923.0
BIOEN,2020/12,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,51411211.0
BIOEN,2020/12,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,11877485.0
BIOEN,2020/12,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2020/12,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2020/12,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,11877485.0
BIOEN,2020/12,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2020/12,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,2609783.0
BIOEN,2020/12,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,14487268.0
BIOEN,2020/3,1A,Dönen Varlıklar,CURRENT ASSETS,0.0
BIOEN,2020/3,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,0.0
BIOEN,2020/3,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2020/3,1AC,Ticari Alacaklar,Short-Term Trade Receivables,0.0
BIOEN,2020/3,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2020/3,1AE,Diğer Alacaklar,Short-Term Other Receivables,0.0
BIOEN,2020/3,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2020/3,1AF,Stoklar,Inventories,0.0
BIOEN,2020/3,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2020/3,1AH,Diğer Dönen Varlıklar,Other Current Assets,0.0
BIOEN,2020/3,1AI,(Ara Toplam),(Subtotal),0.0
BIOEN,2020/3,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2020/3,1AK,Duran Varlıklar,LONG TERM ASSETS,0.0
BIOEN,2020/3,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2020/3,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2020/3,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2020/3,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2020/3,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2020/3,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,0.0
BIOEN,2020/3,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2020/3,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,0.0
BIOEN,2020/3,1BFA,Stoklar,Stoklar,0.0
BIOEN,2020/3,1BFAA,Kullanım Hakkı Varlıkları,nan,0.0
BIOEN,2020/3,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,0.0
BIOEN,2020/3,1BGA,Şerefiye,Goodwill,0.0
BIOEN,2020/3,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,0.0
BIOEN,2020/3,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2020/3,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2020/3,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,0.0
BIOEN,2020/3,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2020/3,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,0.0
BIOEN,2020/3,2AA,Finansal Borçlar,Short-Term Financial Loans,0.0
BIOEN,2020/3,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2020/3,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,0.0
BIOEN,2020/3,2AAGAB,Diğer Borçlar,Other Short-Term Loans,0.0
BIOEN,2020/3,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2020/3,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2020/3,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2020/3,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2020/3,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),0.0
BIOEN,2020/3,2AAGE,Borç Karşılıkları,Short-Term Provisions,0.0
BIOEN,2020/3,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,0.0
BIOEN,2020/3,2AAGG,(Ara Toplam),(Subtotal),0.0
BIOEN,2020/3,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2020/3,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,0.0
BIOEN,2020/3,2BA,Finansal Borçlar,Long-Term Financial Loans,0.0
BIOEN,2020/3,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2020/3,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2020/3,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2020/3,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2020/3,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2020/3,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2020/3,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2020/3,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,0.0
BIOEN,2020/3,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2020/3,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2020/3,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2020/3,2N,Özkaynaklar,SHAREHOLDERS EQUITY,0.0
BIOEN,2020/3,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,0.0
BIOEN,2020/3,2OA,Ödenmiş Sermaye,Share Capital,0.0
BIOEN,2020/3,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2020/3,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,0.0
BIOEN,2020/3,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2020/3,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2020/3,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2020/3,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),0.0
BIOEN,2020/3,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),0.0
BIOEN,2020/3,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,0.0
BIOEN,2020/3,2ODA,Azınlık Payları,Minority Interests,0.0
BIOEN,2020/3,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,0.0
BIOEN,2020/3,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2020/3,3C,Satış Gelirleri,Net Sales,7869665.0
BIOEN,2020/3,3CA,Satışların Maliyeti (-),Cost Of Sales,-5876790.0
BIOEN,2020/3,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2020/3,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,1992875.0
BIOEN,2020/3,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2020/3,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2020/3,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2020/3,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2020/3,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2020/3,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),1992875.0
BIOEN,2020/3,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-71117.0
BIOEN,2020/3,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-624783.0
BIOEN,2020/3,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2020/3,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,195182.0
BIOEN,2020/3,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-956742.0
BIOEN,2020/3,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2020/3,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,535415.0
BIOEN,2020/3,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,1296975.0
BIOEN,2020/3,3HA,Yatırım Faaliyetlerinden Gelirler,nan,4132184.0
BIOEN,2020/3,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2020/3,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2020/3,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,193641.0
BIOEN,2020/3,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,4861240.0
BIOEN,2020/3,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),93774.0
BIOEN,2020/3,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-1991980.0
BIOEN,2020/3,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,4132184.0
BIOEN,2020/3,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,2963033.0
BIOEN,2020/3,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-3922.0
BIOEN,2020/3,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-48469.0
BIOEN,2020/3,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,44547.0
BIOEN,2020/3,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2020/3,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,2959111.0
BIOEN,2020/3,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2020/3,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2020/3,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,2959111.0
BIOEN,2020/3,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2020/3,3LB,Azınlık Payları,Minority Interests,88564.0
BIOEN,2020/3,3Z,Ana Ortaklık Payları,Parent Shares,2870547.0
BIOEN,2020/3,3ZD,Hisse Başına Kazanç,Earnings per Share,2.0
BIOEN,2020/3,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2020/3,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2020/3,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2020/3,4B,Amortisman Giderleri,Depreciation & Amortization,782285.0
BIOEN,2020/3,4BA,Kıdem Tazminatı,Severance Payments,0.0
BIOEN,2020/3,4BB,Finansman Giderleri,Financial Expenses,-1991980.0
BIOEN,2020/3,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2020/3,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2020/3,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,0.0
BIOEN,2020/3,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,0.0
BIOEN,2020/3,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),0.0
BIOEN,2020/3,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,1033323.0
BIOEN,2020/3,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,2959111.0
BIOEN,2020/3,4CAA,Düzeltmeler:,Adjustments:,1332284.0
BIOEN,2020/3,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,782285.0
BIOEN,2020/3,4CAC,Karşılıklardaki Değişim,Change in Provisions,731019.0
BIOEN,2020/3,4CAD,Diğer Gelir/ Gider,Other Income / Expense,-181020.0
BIOEN,2020/3,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),4291394.0
BIOEN,2020/3,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-3045614.0
BIOEN,2020/3,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),1245780.0
BIOEN,2020/3,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-212457.0
BIOEN,2020/3,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-200031.0
BIOEN,2020/3,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,-689430.0
BIOEN,2020/3,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-889461.0
BIOEN,2020/3,4CB,Serbest Nakit Akım,Free Cash Flow,143863.0
BIOEN,2020/3,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,46731.0
BIOEN,2020/3,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2020/3,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2020/3,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-110263.0
BIOEN,2020/3,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,-63532.0
BIOEN,2020/3,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,80331.0
BIOEN,2020/3,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2020/3,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2020/3,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,80331.0
BIOEN,2020/3,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2020/3,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,2999395.0
BIOEN,2020/3,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,3079726.0
BIOEN,2020/6,1A,Dönen Varlıklar,CURRENT ASSETS,0.0
BIOEN,2020/6,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,0.0
BIOEN,2020/6,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2020/6,1AC,Ticari Alacaklar,Short-Term Trade Receivables,0.0
BIOEN,2020/6,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2020/6,1AE,Diğer Alacaklar,Short-Term Other Receivables,0.0
BIOEN,2020/6,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2020/6,1AF,Stoklar,Inventories,0.0
BIOEN,2020/6,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2020/6,1AH,Diğer Dönen Varlıklar,Other Current Assets,0.0
BIOEN,2020/6,1AI,(Ara Toplam),(Subtotal),0.0
BIOEN,2020/6,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2020/6,1AK,Duran Varlıklar,LONG TERM ASSETS,0.0
BIOEN,2020/6,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2020/6,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2020/6,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2020/6,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2020/6,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2020/6,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,0.0
BIOEN,2020/6,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2020/6,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,0.0
BIOEN,2020/6,1BFA,Stoklar,Stoklar,0.0
BIOEN,2020/6,1BFAA,Kullanım Hakkı Varlıkları,nan,0.0
BIOEN,2020/6,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,0.0
BIOEN,2020/6,1BGA,Şerefiye,Goodwill,0.0
BIOEN,2020/6,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,0.0
BIOEN,2020/6,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2020/6,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2020/6,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,0.0
BIOEN,2020/6,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2020/6,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,0.0
BIOEN,2020/6,2AA,Finansal Borçlar,Short-Term Financial Loans,0.0
BIOEN,2020/6,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2020/6,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,0.0
BIOEN,2020/6,2AAGAB,Diğer Borçlar,Other Short-Term Loans,0.0
BIOEN,2020/6,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2020/6,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2020/6,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2020/6,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2020/6,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),0.0
BIOEN,2020/6,2AAGE,Borç Karşılıkları,Short-Term Provisions,0.0
BIOEN,2020/6,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,0.0
BIOEN,2020/6,2AAGG,(Ara Toplam),(Subtotal),0.0
BIOEN,2020/6,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2020/6,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,0.0
BIOEN,2020/6,2BA,Finansal Borçlar,Long-Term Financial Loans,0.0
BIOEN,2020/6,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2020/6,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2020/6,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2020/6,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2020/6,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2020/6,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2020/6,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2020/6,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,0.0
BIOEN,2020/6,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2020/6,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2020/6,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2020/6,2N,Özkaynaklar,SHAREHOLDERS EQUITY,0.0
BIOEN,2020/6,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,0.0
BIOEN,2020/6,2OA,Ödenmiş Sermaye,Share Capital,0.0
BIOEN,2020/6,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2020/6,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,0.0
BIOEN,2020/6,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2020/6,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2020/6,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2020/6,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),0.0
BIOEN,2020/6,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),0.0
BIOEN,2020/6,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,0.0
BIOEN,2020/6,2ODA,Azınlık Payları,Minority Interests,0.0
BIOEN,2020/6,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,0.0
BIOEN,2020/6,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2020/6,3C,Satış Gelirleri,Net Sales,16083737.0
BIOEN,2020/6,3CA,Satışların Maliyeti (-),Cost Of Sales,-11636481.0
BIOEN,2020/6,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2020/6,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,4447256.0
BIOEN,2020/6,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2020/6,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2020/6,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2020/6,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2020/6,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2020/6,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),4447256.0
BIOEN,2020/6,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-136551.0
BIOEN,2020/6,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-1195737.0
BIOEN,2020/6,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2020/6,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,919395.0
BIOEN,2020/6,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-1417102.0
BIOEN,2020/6,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2020/6,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,2617261.0
BIOEN,2020/6,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,3114968.0
BIOEN,2020/6,3HA,Yatırım Faaliyetlerinden Gelirler,nan,3995016.0
BIOEN,2020/6,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2020/6,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2020/6,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,459985.0
BIOEN,2020/6,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,7072261.0
BIOEN,2020/6,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),299371.0
BIOEN,2020/6,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-3375289.0
BIOEN,2020/6,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,3995016.0
BIOEN,2020/6,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,3996344.0
BIOEN,2020/6,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-514254.0
BIOEN,2020/6,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-144996.0
BIOEN,2020/6,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-369258.0
BIOEN,2020/6,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2020/6,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,3482090.0
BIOEN,2020/6,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2020/6,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2020/6,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,3482090.0
BIOEN,2020/6,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2020/6,3LB,Azınlık Payları,Minority Interests,-3118.0
BIOEN,2020/6,3Z,Ana Ortaklık Payları,Parent Shares,3485208.0
BIOEN,2020/6,3ZD,Hisse Başına Kazanç,Earnings per Share,3.0
BIOEN,2020/6,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2020/6,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2020/6,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2020/6,4B,Amortisman Giderleri,Depreciation & Amortization,1329265.0
BIOEN,2020/6,4BA,Kıdem Tazminatı,Severance Payments,0.0
BIOEN,2020/6,4BB,Finansman Giderleri,Financial Expenses,-3375289.0
BIOEN,2020/6,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2020/6,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2020/6,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,0.0
BIOEN,2020/6,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,0.0
BIOEN,2020/6,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),0.0
BIOEN,2020/6,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,5942972.0
BIOEN,2020/6,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,3482090.0
BIOEN,2020/6,4CAA,Düzeltmeler:,Adjustments:,2287063.0
BIOEN,2020/6,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,1329265.0
BIOEN,2020/6,4CAC,Karşılıklardaki Değişim,Change in Provisions,675988.0
BIOEN,2020/6,4CAD,Diğer Gelir/ Gider,Other Income / Expense,281810.0
BIOEN,2020/6,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),5769153.0
BIOEN,2020/6,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,383465.0
BIOEN,2020/6,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),6152618.0
BIOEN,2020/6,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-209646.0
BIOEN,2020/6,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-3024372.0
BIOEN,2020/6,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,-4337741.0
BIOEN,2020/6,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-7362113.0
BIOEN,2020/6,4CB,Serbest Nakit Akım,Free Cash Flow,-1419141.0
BIOEN,2020/6,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,3961517.0
BIOEN,2020/6,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2020/6,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2020/6,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-419215.0
BIOEN,2020/6,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,3542303.0
BIOEN,2020/6,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,2123162.0
BIOEN,2020/6,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2020/6,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2020/6,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,2123162.0
BIOEN,2020/6,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2020/6,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,2830266.0
BIOEN,2020/6,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,4953428.0
BIOEN,2020/9,1A,Dönen Varlıklar,CURRENT ASSETS,0.0
BIOEN,2020/9,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,0.0
BIOEN,2020/9,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2020/9,1AC,Ticari Alacaklar,Short-Term Trade Receivables,0.0
BIOEN,2020/9,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2020/9,1AE,Diğer Alacaklar,Short-Term Other Receivables,0.0
BIOEN,2020/9,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2020/9,1AF,Stoklar,Inventories,0.0
BIOEN,2020/9,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2020/9,1AH,Diğer Dönen Varlıklar,Other Current Assets,0.0
BIOEN,2020/9,1AI,(Ara Toplam),(Subtotal),0.0
BIOEN,2020/9,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2020/9,1AK,Duran Varlıklar,LONG TERM ASSETS,0.0
BIOEN,2020/9,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2020/9,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2020/9,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2020/9,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2020/9,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2020/9,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,0.0
BIOEN,2020/9,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2020/9,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,0.0
BIOEN,2020/9,1BFA,Stoklar,Stoklar,0.0
BIOEN,2020/9,1BFAA,Kullanım Hakkı Varlıkları,nan,0.0
BIOEN,2020/9,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,0.0
BIOEN,2020/9,1BGA,Şerefiye,Goodwill,0.0
BIOEN,2020/9,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,0.0
BIOEN,2020/9,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2020/9,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2020/9,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,0.0
BIOEN,2020/9,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2020/9,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,0.0
BIOEN,2020/9,2AA,Finansal Borçlar,Short-Term Financial Loans,0.0
BIOEN,2020/9,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2020/9,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,0.0
BIOEN,2020/9,2AAGAB,Diğer Borçlar,Other Short-Term Loans,0.0
BIOEN,2020/9,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2020/9,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2020/9,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2020/9,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2020/9,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),0.0
BIOEN,2020/9,2AAGE,Borç Karşılıkları,Short-Term Provisions,0.0
BIOEN,2020/9,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,0.0
BIOEN,2020/9,2AAGG,(Ara Toplam),(Subtotal),0.0
BIOEN,2020/9,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2020/9,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,0.0
BIOEN,2020/9,2BA,Finansal Borçlar,Long-Term Financial Loans,0.0
BIOEN,2020/9,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2020/9,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2020/9,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2020/9,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2020/9,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2020/9,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2020/9,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2020/9,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,0.0
BIOEN,2020/9,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2020/9,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2020/9,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2020/9,2N,Özkaynaklar,SHAREHOLDERS EQUITY,0.0
BIOEN,2020/9,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,0.0
BIOEN,2020/9,2OA,Ödenmiş Sermaye,Share Capital,0.0
BIOEN,2020/9,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2020/9,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,0.0
BIOEN,2020/9,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2020/9,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2020/9,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2020/9,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),0.0
BIOEN,2020/9,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),0.0
BIOEN,2020/9,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,0.0
BIOEN,2020/9,2ODA,Azınlık Payları,Minority Interests,0.0
BIOEN,2020/9,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,0.0
BIOEN,2020/9,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2020/9,3C,Satış Gelirleri,Net Sales,25067470.0
BIOEN,2020/9,3CA,Satışların Maliyeti (-),Cost Of Sales,-18313312.0
BIOEN,2020/9,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2020/9,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,6754158.0
BIOEN,2020/9,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2020/9,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2020/9,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2020/9,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2020/9,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2020/9,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),6754158.0
BIOEN,2020/9,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-131393.0
BIOEN,2020/9,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-2032068.0
BIOEN,2020/9,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2020/9,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,5817704.0
BIOEN,2020/9,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-6599822.0
BIOEN,2020/9,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2020/9,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,3808578.0
BIOEN,2020/9,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,4590697.0
BIOEN,2020/9,3HA,Yatırım Faaliyetlerinden Gelirler,nan,3936322.0
BIOEN,2020/9,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2020/9,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2020/9,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,874562.0
BIOEN,2020/9,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,8619462.0
BIOEN,2020/9,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),395798.0
BIOEN,2020/9,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-5667884.0
BIOEN,2020/9,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,3936322.0
BIOEN,2020/9,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,3347377.0
BIOEN,2020/9,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-541048.0
BIOEN,2020/9,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-339793.0
BIOEN,2020/9,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-201256.0
BIOEN,2020/9,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2020/9,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,2806328.0
BIOEN,2020/9,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2020/9,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2020/9,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,2806328.0
BIOEN,2020/9,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2020/9,3LB,Azınlık Payları,Minority Interests,-5970.0
BIOEN,2020/9,3Z,Ana Ortaklık Payları,Parent Shares,2812299.0
BIOEN,2020/9,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2020/9,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2020/9,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2020/9,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2020/9,4B,Amortisman Giderleri,Depreciation & Amortization,1941635.0
BIOEN,2020/9,4BA,Kıdem Tazminatı,Severance Payments,0.0
BIOEN,2020/9,4BB,Finansman Giderleri,Financial Expenses,-5667884.0
BIOEN,2020/9,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2020/9,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2020/9,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,0.0
BIOEN,2020/9,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,0.0
BIOEN,2020/9,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),0.0
BIOEN,2020/9,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,-8973644.0
BIOEN,2020/9,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,2806328.0
BIOEN,2020/9,4CAA,Düzeltmeler:,Adjustments:,2935659.0
BIOEN,2020/9,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,1941635.0
BIOEN,2020/9,4CAC,Karşılıklardaki Değişim,Change in Provisions,650397.0
BIOEN,2020/9,4CAD,Diğer Gelir/ Gider,Other Income / Expense,343627.0
BIOEN,2020/9,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),5741987.0
BIOEN,2020/9,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-14460641.0
BIOEN,2020/9,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),-8718654.0
BIOEN,2020/9,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-254990.0
BIOEN,2020/9,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-7827452.0
BIOEN,2020/9,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,-4306359.0
BIOEN,2020/9,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-12133811.0
BIOEN,2020/9,4CB,Serbest Nakit Akım,Free Cash Flow,-21107455.0
BIOEN,2020/9,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,18401747.0
BIOEN,2020/9,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2020/9,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2020/9,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,2812230.0
BIOEN,2020/9,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,21213977.0
BIOEN,2020/9,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,106522.0
BIOEN,2020/9,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2020/9,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2020/9,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,106522.0
BIOEN,2020/9,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2020/9,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,2723353.0
BIOEN,2020/9,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,2829875.0
BIOEN,2021/12,1A,Dönen Varlıklar,CURRENT ASSETS,51144028.0
BIOEN,2021/12,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,12796098.0
BIOEN,2021/12,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2021/12,1AC,Ticari Alacaklar,Short-Term Trade Receivables,7816204.0
BIOEN,2021/12,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2021/12,1AE,Diğer Alacaklar,Short-Term Other Receivables,1717484.0
BIOEN,2021/12,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2021/12,1AF,Stoklar,Inventories,4767433.0
BIOEN,2021/12,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2021/12,1AH,Diğer Dönen Varlıklar,Other Current Assets,24046809.0
BIOEN,2021/12,1AI,(Ara Toplam),(Subtotal),51144028.0
BIOEN,2021/12,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2021/12,1AK,Duran Varlıklar,LONG TERM ASSETS,86057204.0
BIOEN,2021/12,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2021/12,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2021/12,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2021/12,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2021/12,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2021/12,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,3822732.0
BIOEN,2021/12,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2021/12,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,693178.0
BIOEN,2021/12,1BFA,Stoklar,Stoklar,0.0
BIOEN,2021/12,1BFAA,Kullanım Hakkı Varlıkları,nan,5533006.0
BIOEN,2021/12,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,66974548.0
BIOEN,2021/12,1BGA,Şerefiye,Goodwill,489178.0
BIOEN,2021/12,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,4088560.0
BIOEN,2021/12,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2021/12,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,4456001.0
BIOEN,2021/12,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,137201232.0
BIOEN,2021/12,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2021/12,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,35481373.0
BIOEN,2021/12,2AA,Finansal Borçlar,Short-Term Financial Loans,14338997.0
BIOEN,2021/12,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2021/12,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,16301613.0
BIOEN,2021/12,2AAGAB,Diğer Borçlar,Other Short-Term Loans,3302954.0
BIOEN,2021/12,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2021/12,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2021/12,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2021/12,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,204618.0
BIOEN,2021/12,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),245006.0
BIOEN,2021/12,2AAGE,Borç Karşılıkları,Short-Term Provisions,792326.0
BIOEN,2021/12,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,295857.0
BIOEN,2021/12,2AAGG,(Ara Toplam),(Subtotal),35481373.0
BIOEN,2021/12,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2021/12,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,59881328.0
BIOEN,2021/12,2BA,Finansal Borçlar,Long-Term Financial Loans,58289229.0
BIOEN,2021/12,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2021/12,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2021/12,2BBB,Diğer Borçlar,Other Long-Term Loans,198564.0
BIOEN,2021/12,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2021/12,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2021/12,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2021/12,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2021/12,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,130529.0
BIOEN,2021/12,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2021/12,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2021/12,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,1263006.0
BIOEN,2021/12,2N,Özkaynaklar,SHAREHOLDERS EQUITY,41838531.0
BIOEN,2021/12,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,42042270.0
BIOEN,2021/12,2OA,Ödenmiş Sermaye,Share Capital,37444769.0
BIOEN,2021/12,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2021/12,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,1987671.0
BIOEN,2021/12,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2021/12,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2021/12,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2021/12,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),3005323.0
BIOEN,2021/12,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),489928.0
BIOEN,2021/12,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,-885421.0
BIOEN,2021/12,2ODA,Azınlık Payları,Minority Interests,-203738.0
BIOEN,2021/12,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,137201232.0
BIOEN,2021/12,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2021/12,3C,Satış Gelirleri,Net Sales,47921217.0
BIOEN,2021/12,3CA,Satışların Maliyeti (-),Cost Of Sales,-34102240.0
BIOEN,2021/12,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2021/12,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,13818977.0
BIOEN,2021/12,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2021/12,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2021/12,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2021/12,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2021/12,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2021/12,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),13818977.0
BIOEN,2021/12,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-286650.0
BIOEN,2021/12,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-4471659.0
BIOEN,2021/12,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2021/12,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,2490984.0
BIOEN,2021/12,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-5850532.0
BIOEN,2021/12,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2021/12,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,5701119.0
BIOEN,2021/12,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,9060667.0
BIOEN,2021/12,3HA,Yatırım Faaliyetlerinden Gelirler,nan,717517.0
BIOEN,2021/12,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2021/12,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2021/12,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,2884245.0
BIOEN,2021/12,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,9302881.0
BIOEN,2021/12,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),5988288.0
BIOEN,2021/12,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-12666878.0
BIOEN,2021/12,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,717517.0
BIOEN,2021/12,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,2624292.0
BIOEN,2021/12,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-2176669.0
BIOEN,2021/12,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-1276450.0
BIOEN,2021/12,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-900219.0
BIOEN,2021/12,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2021/12,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,447623.0
BIOEN,2021/12,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2021/12,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2021/12,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,447623.0
BIOEN,2021/12,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2021/12,3LB,Azınlık Payları,Minority Interests,-285363.0
BIOEN,2021/12,3Z,Ana Ortaklık Payları,Parent Shares,732986.0
BIOEN,2021/12,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2021/12,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2021/12,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2021/12,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2021/12,4B,Amortisman Giderleri,Depreciation & Amortization,3693715.0
BIOEN,2021/12,4BA,Kıdem Tazminatı,Severance Payments,90702.0
BIOEN,2021/12,4BB,Finansman Giderleri,Financial Expenses,-12666878.0
BIOEN,2021/12,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2021/12,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2021/12,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-73568344.0
BIOEN,2021/12,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-89806857.0
BIOEN,2021/12,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-73568344.0
BIOEN,2021/12,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,-36546072.0
BIOEN,2021/12,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,447623.0
BIOEN,2021/12,4CAA,Düzeltmeler:,Adjustments:,4166177.0
BIOEN,2021/12,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,3693715.0
BIOEN,2021/12,4CAC,Karşılıklardaki Değişim,Change in Provisions,751894.0
BIOEN,2021/12,4CAD,Diğer Gelir/ Gider,Other Income / Expense,-279432.0
BIOEN,2021/12,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),4613800.0
BIOEN,2021/12,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-39686143.0
BIOEN,2021/12,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),-35072344.0
BIOEN,2021/12,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-1473729.0
BIOEN,2021/12,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-49295427.0
BIOEN,2021/12,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,0.0
BIOEN,2021/12,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-49295427.0
BIOEN,2021/12,4CB,Serbest Nakit Akım,Free Cash Flow,-85841499.0
BIOEN,2021/12,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,53680809.0
BIOEN,2021/12,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2021/12,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2021/12,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,39897972.0
BIOEN,2021/12,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,93578781.0
BIOEN,2021/12,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,7737283.0
BIOEN,2021/12,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2021/12,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2021/12,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,7737283.0
BIOEN,2021/12,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2021/12,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,11407088.0
BIOEN,2021/12,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,19144371.0
BIOEN,2021/3,1A,Dönen Varlıklar,CURRENT ASSETS,26768032.0
BIOEN,2021/3,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,3106022.0
BIOEN,2021/3,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2021/3,1AC,Ticari Alacaklar,Short-Term Trade Receivables,3770021.0
BIOEN,2021/3,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2021/3,1AE,Diğer Alacaklar,Short-Term Other Receivables,1789028.0
BIOEN,2021/3,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2021/3,1AF,Stoklar,Inventories,702928.0
BIOEN,2021/3,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2021/3,1AH,Diğer Dönen Varlıklar,Other Current Assets,17400033.0
BIOEN,2021/3,1AI,(Ara Toplam),(Subtotal),26768032.0
BIOEN,2021/3,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2021/3,1AK,Duran Varlıklar,LONG TERM ASSETS,89423378.0
BIOEN,2021/3,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2021/3,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2021/3,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2021/3,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2021/3,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2021/3,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,3631113.0
BIOEN,2021/3,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2021/3,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,394669.0
BIOEN,2021/3,1BFA,Stoklar,Stoklar,0.0
BIOEN,2021/3,1BFAA,Kullanım Hakkı Varlıkları,nan,4457652.0
BIOEN,2021/3,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,71369645.0
BIOEN,2021/3,1BGA,Şerefiye,Goodwill,783138.0
BIOEN,2021/3,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,6854703.0
BIOEN,2021/3,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2021/3,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,1932457.0
BIOEN,2021/3,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,116191410.0
BIOEN,2021/3,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2021/3,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,34691321.0
BIOEN,2021/3,2AA,Finansal Borçlar,Short-Term Financial Loans,12815219.0
BIOEN,2021/3,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2021/3,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,16639360.0
BIOEN,2021/3,2AAGAB,Diğer Borçlar,Other Short-Term Loans,4004490.0
BIOEN,2021/3,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2021/3,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2021/3,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2021/3,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,354298.0
BIOEN,2021/3,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),0.0
BIOEN,2021/3,2AAGE,Borç Karşılıkları,Short-Term Provisions,562691.0
BIOEN,2021/3,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,315263.0
BIOEN,2021/3,2AAGG,(Ara Toplam),(Subtotal),34691321.0
BIOEN,2021/3,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2021/3,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,52393806.0
BIOEN,2021/3,2BA,Finansal Borçlar,Long-Term Financial Loans,47951858.0
BIOEN,2021/3,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2021/3,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2021/3,2BBB,Diğer Borçlar,Other Long-Term Loans,529812.0
BIOEN,2021/3,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2021/3,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2021/3,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2021/3,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,223372.0
BIOEN,2021/3,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,127106.0
BIOEN,2021/3,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2021/3,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,3561658.0
BIOEN,2021/3,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2021/3,2N,Özkaynaklar,SHAREHOLDERS EQUITY,29106283.0
BIOEN,2021/3,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,29095659.0
BIOEN,2021/3,2OA,Ödenmiş Sermaye,Share Capital,15346250.0
BIOEN,2021/3,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2021/3,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,0.0
BIOEN,2021/3,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2021/3,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2021/3,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2021/3,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),6742314.0
BIOEN,2021/3,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),851639.0
BIOEN,2021/3,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,6155456.0
BIOEN,2021/3,2ODA,Azınlık Payları,Minority Interests,10624.0
BIOEN,2021/3,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,116191410.0
BIOEN,2021/3,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2021/3,3C,Satış Gelirleri,Net Sales,9036429.0
BIOEN,2021/3,3CA,Satışların Maliyeti (-),Cost Of Sales,-6764756.0
BIOEN,2021/3,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2021/3,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,2271673.0
BIOEN,2021/3,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2021/3,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2021/3,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2021/3,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2021/3,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2021/3,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),2271673.0
BIOEN,2021/3,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-132836.0
BIOEN,2021/3,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-783338.0
BIOEN,2021/3,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2021/3,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,2256426.0
BIOEN,2021/3,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-1366271.0
BIOEN,2021/3,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2021/3,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,2245653.0
BIOEN,2021/3,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,1355498.0
BIOEN,2021/3,3HA,Yatırım Faaliyetlerinden Gelirler,nan,83866.0
BIOEN,2021/3,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2021/3,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2021/3,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,673017.0
BIOEN,2021/3,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,3002535.0
BIOEN,2021/3,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),268577.0
BIOEN,2021/3,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-1666097.0
BIOEN,2021/3,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,83866.0
BIOEN,2021/3,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,1605015.0
BIOEN,2021/3,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-610353.0
BIOEN,2021/3,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),0.0
BIOEN,2021/3,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-610353.0
BIOEN,2021/3,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2021/3,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,994662.0
BIOEN,2021/3,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2021/3,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2021/3,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,994662.0
BIOEN,2021/3,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2021/3,3LB,Azınlık Payları,Minority Interests,35411.0
BIOEN,2021/3,3Z,Ana Ortaklık Payları,Parent Shares,959251.0
BIOEN,2021/3,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2021/3,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2021/3,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2021/3,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2021/3,4B,Amortisman Giderleri,Depreciation & Amortization,878822.0
BIOEN,2021/3,4BA,Kıdem Tazminatı,Severance Payments,59765.0
BIOEN,2021/3,4BB,Finansman Giderleri,Financial Expenses,-1666097.0
BIOEN,2021/3,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2021/3,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2021/3,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-16484872.0
BIOEN,2021/3,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-21837531.0
BIOEN,2021/3,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-16484872.0
BIOEN,2021/3,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,-989831.0
BIOEN,2021/3,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,994662.0
BIOEN,2021/3,4CAA,Düzeltmeler:,Adjustments:,2122829.0
BIOEN,2021/3,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,878822.0
BIOEN,2021/3,4CAC,Karşılıklardaki Değişim,Change in Provisions,63173.0
BIOEN,2021/3,4CAD,Diğer Gelir/ Gider,Other Income / Expense,1180834.0
BIOEN,2021/3,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),3117491.0
BIOEN,2021/3,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-3427749.0
BIOEN,2021/3,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),-310258.0
BIOEN,2021/3,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-679573.0
BIOEN,2021/3,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-16175168.0
BIOEN,2021/3,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,0.0
BIOEN,2021/3,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-16175168.0
BIOEN,2021/3,4CB,Serbest Nakit Akım,Free Cash Flow,-17164999.0
BIOEN,2021/3,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,7137268.0
BIOEN,2021/3,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2021/3,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2021/3,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-222390.0
BIOEN,2021/3,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,6914878.0
BIOEN,2021/3,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,-10250121.0
BIOEN,2021/3,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2021/3,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2021/3,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,-10250121.0
BIOEN,2021/3,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2021/3,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,13748613.0
BIOEN,2021/3,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,3498493.0
BIOEN,2021/6,1A,Dönen Varlıklar,CURRENT ASSETS,59736208.0
BIOEN,2021/6,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,23304236.0
BIOEN,2021/6,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2021/6,1AC,Ticari Alacaklar,Short-Term Trade Receivables,4667191.0
BIOEN,2021/6,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2021/6,1AE,Diğer Alacaklar,Short-Term Other Receivables,15868333.0
BIOEN,2021/6,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2021/6,1AF,Stoklar,Inventories,1091169.0
BIOEN,2021/6,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2021/6,1AH,Diğer Dönen Varlıklar,Other Current Assets,14805278.0
BIOEN,2021/6,1AI,(Ara Toplam),(Subtotal),59736208.0
BIOEN,2021/6,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2021/6,1AK,Duran Varlıklar,LONG TERM ASSETS,100306123.0
BIOEN,2021/6,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2021/6,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2021/6,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2021/6,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2021/6,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2021/6,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,3858289.0
BIOEN,2021/6,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2021/6,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,378553.0
BIOEN,2021/6,1BFA,Stoklar,Stoklar,0.0
BIOEN,2021/6,1BFAA,Kullanım Hakkı Varlıkları,nan,4239370.0
BIOEN,2021/6,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,82207147.0
BIOEN,2021/6,1BGA,Şerefiye,Goodwill,0.0
BIOEN,2021/6,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,7186003.0
BIOEN,2021/6,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2021/6,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,2436762.0
BIOEN,2021/6,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,160042331.0
BIOEN,2021/6,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2021/6,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,34605386.0
BIOEN,2021/6,2AA,Finansal Borçlar,Short-Term Financial Loans,19079546.0
BIOEN,2021/6,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2021/6,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,11040357.0
BIOEN,2021/6,2AAGAB,Diğer Borçlar,Other Short-Term Loans,2588530.0
BIOEN,2021/6,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2021/6,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2021/6,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2021/6,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,796233.0
BIOEN,2021/6,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),44439.0
BIOEN,2021/6,2AAGE,Borç Karşılıkları,Short-Term Provisions,540806.0
BIOEN,2021/6,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,515476.0
BIOEN,2021/6,2AAGG,(Ara Toplam),(Subtotal),34605386.0
BIOEN,2021/6,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2021/6,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,52598500.0
BIOEN,2021/6,2BA,Finansal Borçlar,Long-Term Financial Loans,48763098.0
BIOEN,2021/6,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2021/6,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2021/6,2BBB,Diğer Borçlar,Other Long-Term Loans,508177.0
BIOEN,2021/6,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2021/6,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2021/6,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2021/6,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,142834.0
BIOEN,2021/6,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,141817.0
BIOEN,2021/6,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2021/6,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,3042575.0
BIOEN,2021/6,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2021/6,2N,Özkaynaklar,SHAREHOLDERS EQUITY,72838445.0
BIOEN,2021/6,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,72854606.0
BIOEN,2021/6,2OA,Ödenmiş Sermaye,Share Capital,17249508.0
BIOEN,2021/6,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2021/6,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,0.0
BIOEN,2021/6,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2021/6,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2021/6,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2021/6,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),6466989.0
BIOEN,2021/6,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),2092707.0
BIOEN,2021/6,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,47045402.0
BIOEN,2021/6,2ODA,Azınlık Payları,Minority Interests,-16162.0
BIOEN,2021/6,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,160042331.0
BIOEN,2021/6,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2021/6,3C,Satış Gelirleri,Net Sales,20219648.0
BIOEN,2021/6,3CA,Satışların Maliyeti (-),Cost Of Sales,-15288651.0
BIOEN,2021/6,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2021/6,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,4930997.0
BIOEN,2021/6,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2021/6,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2021/6,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2021/6,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2021/6,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2021/6,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),4930997.0
BIOEN,2021/6,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-126979.0
BIOEN,2021/6,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-1753726.0
BIOEN,2021/6,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2021/6,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,3744765.0
BIOEN,2021/6,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-3659490.0
BIOEN,2021/6,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2021/6,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,3135568.0
BIOEN,2021/6,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,3050292.0
BIOEN,2021/6,3HA,Yatırım Faaliyetlerinden Gelirler,nan,157426.0
BIOEN,2021/6,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2021/6,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2021/6,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,1045480.0
BIOEN,2021/6,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,4338474.0
BIOEN,2021/6,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),1508898.0
BIOEN,2021/6,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-3217714.0
BIOEN,2021/6,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,157426.0
BIOEN,2021/6,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,2629658.0
BIOEN,2021/6,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-318958.0
BIOEN,2021/6,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-155945.0
BIOEN,2021/6,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-163013.0
BIOEN,2021/6,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2021/6,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,2310700.0
BIOEN,2021/6,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2021/6,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2021/6,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,2310700.0
BIOEN,2021/6,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2021/6,3LB,Azınlık Payları,Minority Interests,4191.0
BIOEN,2021/6,3Z,Ana Ortaklık Payları,Parent Shares,2306509.0
BIOEN,2021/6,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2021/6,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2021/6,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2021/6,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2021/6,4B,Amortisman Giderleri,Depreciation & Amortization,1763669.0
BIOEN,2021/6,4BA,Kıdem Tazminatı,Severance Payments,67254.0
BIOEN,2021/6,4BB,Finansman Giderleri,Financial Expenses,-3217714.0
BIOEN,2021/6,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2021/6,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2021/6,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-47772600.0
BIOEN,2021/6,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-50865348.0
BIOEN,2021/6,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-47772600.0
BIOEN,2021/6,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,-21499303.0
BIOEN,2021/6,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,2310700.0
BIOEN,2021/6,4CAA,Düzeltmeler:,Adjustments:,2825002.0
BIOEN,2021/6,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,1763669.0
BIOEN,2021/6,4CAC,Karşılıklardaki Değişim,Change in Provisions,72558.0
BIOEN,2021/6,4CAD,Diğer Gelir/ Gider,Other Income / Expense,988775.0
BIOEN,2021/6,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),5135702.0
BIOEN,2021/6,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-25890218.0
BIOEN,2021/6,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),-20754515.0
BIOEN,2021/6,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-744788.0
BIOEN,2021/6,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-31044175.0
BIOEN,2021/6,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,0.0
BIOEN,2021/6,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-31044175.0
BIOEN,2021/6,4CB,Serbest Nakit Akım,Free Cash Flow,-52543479.0
BIOEN,2021/6,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,17272141.0
BIOEN,2021/6,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2021/6,4CBC,Sermaye Artırımı,Rights Issue,48140826.0
BIOEN,2021/6,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-88304.0
BIOEN,2021/6,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,65324662.0
BIOEN,2021/6,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,12781184.0
BIOEN,2021/6,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2021/6,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2021/6,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,12781184.0
BIOEN,2021/6,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2021/6,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,12903941.0
BIOEN,2021/6,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,25685125.0
BIOEN,2021/9,1A,Dönen Varlıklar,CURRENT ASSETS,69179303.0
BIOEN,2021/9,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,22167813.0
BIOEN,2021/9,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2021/9,1AC,Ticari Alacaklar,Short-Term Trade Receivables,8803021.0
BIOEN,2021/9,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2021/9,1AE,Diğer Alacaklar,Short-Term Other Receivables,13303472.0
BIOEN,2021/9,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2021/9,1AF,Stoklar,Inventories,4426146.0
BIOEN,2021/9,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2021/9,1AH,Diğer Dönen Varlıklar,Other Current Assets,20478850.0
BIOEN,2021/9,1AI,(Ara Toplam),(Subtotal),69179303.0
BIOEN,2021/9,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2021/9,1AK,Duran Varlıklar,LONG TERM ASSETS,102447244.0
BIOEN,2021/9,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2021/9,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2021/9,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2021/9,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2021/9,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2021/9,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,4255278.0
BIOEN,2021/9,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2021/9,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,370100.0
BIOEN,2021/9,1BFA,Stoklar,Stoklar,0.0
BIOEN,2021/9,1BFAA,Kullanım Hakkı Varlıkları,nan,4102579.0
BIOEN,2021/9,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,84425473.0
BIOEN,2021/9,1BGA,Şerefiye,Goodwill,734386.0
BIOEN,2021/9,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,6134766.0
BIOEN,2021/9,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2021/9,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,2424661.0
BIOEN,2021/9,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,171626547.0
BIOEN,2021/9,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2021/9,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,43728590.0
BIOEN,2021/9,2AA,Finansal Borçlar,Short-Term Financial Loans,24219477.0
BIOEN,2021/9,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2021/9,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,13303357.0
BIOEN,2021/9,2AAGAB,Diğer Borçlar,Other Short-Term Loans,3846243.0
BIOEN,2021/9,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2021/9,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2021/9,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2021/9,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,955675.0
BIOEN,2021/9,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),163332.0
BIOEN,2021/9,2AAGE,Borç Karşılıkları,Short-Term Provisions,612809.0
BIOEN,2021/9,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,627696.0
BIOEN,2021/9,2AAGG,(Ara Toplam),(Subtotal),43728590.0
BIOEN,2021/9,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2021/9,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,55431558.0
BIOEN,2021/9,2BA,Finansal Borçlar,Long-Term Financial Loans,51796984.0
BIOEN,2021/9,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2021/9,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2021/9,2BBB,Diğer Borçlar,Other Long-Term Loans,347781.0
BIOEN,2021/9,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2021/9,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2021/9,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2021/9,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,69822.0
BIOEN,2021/9,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,145844.0
BIOEN,2021/9,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2021/9,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,3071126.0
BIOEN,2021/9,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2021/9,2N,Özkaynaklar,SHAREHOLDERS EQUITY,72466400.0
BIOEN,2021/9,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,72568974.0
BIOEN,2021/9,2OA,Ödenmiş Sermaye,Share Capital,16864354.0
BIOEN,2021/9,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2021/9,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,40229693.0
BIOEN,2021/9,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2021/9,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2021/9,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2021/9,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),6322591.0
BIOEN,2021/9,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),3399966.0
BIOEN,2021/9,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,5752370.0
BIOEN,2021/9,2ODA,Azınlık Payları,Minority Interests,-102575.0
BIOEN,2021/9,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,171626547.0
BIOEN,2021/9,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2021/9,3C,Satış Gelirleri,Net Sales,32220649.0
BIOEN,2021/9,3CA,Satışların Maliyeti (-),Cost Of Sales,-24752721.0
BIOEN,2021/9,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2021/9,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,7467928.0
BIOEN,2021/9,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2021/9,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2021/9,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2021/9,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2021/9,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2021/9,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),7467928.0
BIOEN,2021/9,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-245905.0
BIOEN,2021/9,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-3207938.0
BIOEN,2021/9,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2021/9,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,5368690.0
BIOEN,2021/9,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-3704989.0
BIOEN,2021/9,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2021/9,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,5677786.0
BIOEN,2021/9,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,4014085.0
BIOEN,2021/9,3HA,Yatırım Faaliyetlerinden Gelirler,nan,229899.0
BIOEN,2021/9,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2021/9,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2021/9,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,1548123.0
BIOEN,2021/9,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,7455809.0
BIOEN,2021/9,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),7989203.0
BIOEN,2021/9,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-11280786.0
BIOEN,2021/9,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,229899.0
BIOEN,2021/9,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,4164225.0
BIOEN,2021/9,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-523755.0
BIOEN,2021/9,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-256323.0
BIOEN,2021/9,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-267432.0
BIOEN,2021/9,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2021/9,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,3640470.0
BIOEN,2021/9,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2021/9,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2021/9,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,3640470.0
BIOEN,2021/9,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2021/9,3LB,Azınlık Payları,Minority Interests,-91158.0
BIOEN,2021/9,3Z,Ana Ortaklık Payları,Parent Shares,3731628.0
BIOEN,2021/9,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2021/9,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2021/9,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2021/9,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2021/9,4B,Amortisman Giderleri,Depreciation & Amortization,2735794.0
BIOEN,2021/9,4BA,Kıdem Tazminatı,Severance Payments,56812.0
BIOEN,2021/9,4BB,Finansman Giderleri,Financial Expenses,-11280786.0
BIOEN,2021/9,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2021/9,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2021/9,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-32709577.0
BIOEN,2021/9,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-32709577.0
BIOEN,2021/9,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-32709577.0
BIOEN,2021/9,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,-25172104.0
BIOEN,2021/9,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,3640470.0
BIOEN,2021/9,4CAA,Düzeltmeler:,Adjustments:,5454497.0
BIOEN,2021/9,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,2735794.0
BIOEN,2021/9,4CAC,Karşılıklardaki Değişim,Change in Provisions,153131.0
BIOEN,2021/9,4CAD,Diğer Gelir/ Gider,Other Income / Expense,2565572.0
BIOEN,2021/9,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),9094967.0
BIOEN,2021/9,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-33569044.0
BIOEN,2021/9,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),-24474077.0
BIOEN,2021/9,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-698027.0
BIOEN,2021/9,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-35443642.0
BIOEN,2021/9,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,0.0
BIOEN,2021/9,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-35443642.0
BIOEN,2021/9,4CB,Serbest Nakit Akım,Free Cash Flow,-60615745.0
BIOEN,2021/9,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,46868763.0
BIOEN,2021/9,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2021/9,4CBC,Sermaye Artırımı,Rights Issue,-1981471.0
BIOEN,2021/9,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,27495737.0
BIOEN,2021/9,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,72383028.0
BIOEN,2021/9,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,11767283.0
BIOEN,2021/9,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2021/9,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2021/9,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,11767283.0
BIOEN,2021/9,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2021/9,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,12562970.0
BIOEN,2021/9,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,24330253.0
BIOEN,2022/12,1A,Dönen Varlıklar,CURRENT ASSETS,108116345.0
BIOEN,2022/12,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,2431287.0
BIOEN,2022/12,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2022/12,1AC,Ticari Alacaklar,Short-Term Trade Receivables,29592532.0
BIOEN,2022/12,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2022/12,1AE,Diğer Alacaklar,Short-Term Other Receivables,831448.0
BIOEN,2022/12,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2022/12,1AF,Stoklar,Inventories,10412240.0
BIOEN,2022/12,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2022/12,1AH,Diğer Dönen Varlıklar,Other Current Assets,64848837.0
BIOEN,2022/12,1AI,(Ara Toplam),(Subtotal),108116345.0
BIOEN,2022/12,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2022/12,1AK,Duran Varlıklar,LONG TERM ASSETS,246572423.0
BIOEN,2022/12,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2022/12,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2022/12,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2022/12,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2022/12,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2022/12,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,12591880.0
BIOEN,2022/12,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2022/12,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,1564868.0
BIOEN,2022/12,1BFA,Stoklar,Stoklar,0.0
BIOEN,2022/12,1BFAA,Kullanım Hakkı Varlıkları,nan,4996800.0
BIOEN,2022/12,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,210964912.0
BIOEN,2022/12,1BGA,Şerefiye,Goodwill,2065697.0
BIOEN,2022/12,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,14388267.0
BIOEN,2022/12,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2022/12,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2022/12,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,354688768.0
BIOEN,2022/12,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2022/12,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,107186617.0
BIOEN,2022/12,2AA,Finansal Borçlar,Short-Term Financial Loans,39130647.0
BIOEN,2022/12,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2022/12,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,60258468.0
BIOEN,2022/12,2AAGAB,Diğer Borçlar,Other Short-Term Loans,4313024.0
BIOEN,2022/12,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2022/12,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2022/12,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2022/12,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,714494.0
BIOEN,2022/12,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),89234.0
BIOEN,2022/12,2AAGE,Borç Karşılıkları,Short-Term Provisions,1416220.0
BIOEN,2022/12,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1264531.0
BIOEN,2022/12,2AAGG,(Ara Toplam),(Subtotal),107186617.0
BIOEN,2022/12,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2022/12,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,115365167.0
BIOEN,2022/12,2BA,Finansal Borçlar,Long-Term Financial Loans,112245721.0
BIOEN,2022/12,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2022/12,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2022/12,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2022/12,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2022/12,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2022/12,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2022/12,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2022/12,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,474645.0
BIOEN,2022/12,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2022/12,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,2644801.0
BIOEN,2022/12,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2022/12,2N,Özkaynaklar,SHAREHOLDERS EQUITY,132136983.0
BIOEN,2022/12,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,131597618.0
BIOEN,2022/12,2OA,Ödenmiş Sermaye,Share Capital,26692291.0
BIOEN,2022/12,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2022/12,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,5628208.0
BIOEN,2022/12,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2022/12,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2022/12,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2022/12,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),21181164.0
BIOEN,2022/12,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),30790039.0
BIOEN,2022/12,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,47305915.0
BIOEN,2022/12,2ODA,Azınlık Payları,Minority Interests,539366.0
BIOEN,2022/12,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,354688768.0
BIOEN,2022/12,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2022/12,3C,Satış Gelirleri,Net Sales,140697425.0
BIOEN,2022/12,3CA,Satışların Maliyeti (-),Cost Of Sales,-92726180.0
BIOEN,2022/12,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2022/12,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,47971245.0
BIOEN,2022/12,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2022/12,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2022/12,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2022/12,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2022/12,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2022/12,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),47971245.0
BIOEN,2022/12,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-396895.0
BIOEN,2022/12,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-14606097.0
BIOEN,2022/12,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2022/12,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,11802295.0
BIOEN,2022/12,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-8242895.0
BIOEN,2022/12,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2022/12,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,36527652.0
BIOEN,2022/12,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,32968252.0
BIOEN,2022/12,3HA,Yatırım Faaliyetlerinden Gelirler,nan,535182.0
BIOEN,2022/12,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2022/12,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2022/12,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,2470432.0
BIOEN,2022/12,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,39533266.0
BIOEN,2022/12,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),12572194.0
BIOEN,2022/12,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-10860659.0
BIOEN,2022/12,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,535182.0
BIOEN,2022/12,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,41244801.0
BIOEN,2022/12,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-6543946.0
BIOEN,2022/12,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-1613361.0
BIOEN,2022/12,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-4930584.0
BIOEN,2022/12,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2022/12,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,34700855.0
BIOEN,2022/12,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2022/12,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2022/12,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,34700855.0
BIOEN,2022/12,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2022/12,3LB,Azınlık Payları,Minority Interests,-12274.0
BIOEN,2022/12,3Z,Ana Ortaklık Payları,Parent Shares,34713129.0
BIOEN,2022/12,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2022/12,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2022/12,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2022/12,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2022/12,4B,Amortisman Giderleri,Depreciation & Amortization,17921596.0
BIOEN,2022/12,4BA,Kıdem Tazminatı,Severance Payments,223767.0
BIOEN,2022/12,4BB,Finansman Giderleri,Financial Expenses,-10860659.0
BIOEN,2022/12,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2022/12,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2022/12,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-140728556.0
BIOEN,2022/12,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-176282266.0
BIOEN,2022/12,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-140728556.0
BIOEN,2022/12,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,65786976.0
BIOEN,2022/12,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,34700855.0
BIOEN,2022/12,4CAA,Düzeltmeler:,Adjustments:,28742196.0
BIOEN,2022/12,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,17921596.0
BIOEN,2022/12,4CAC,Karşılıklardaki Değişim,Change in Provisions,-1559220.0
BIOEN,2022/12,4CAD,Diğer Gelir/ Gider,Other Income / Expense,12379820.0
BIOEN,2022/12,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),63443051.0
BIOEN,2022/12,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,2776286.0
BIOEN,2022/12,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),66219337.0
BIOEN,2022/12,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-432361.0
BIOEN,2022/12,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-86012587.0
BIOEN,2022/12,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,-1126040.0
BIOEN,2022/12,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-87138627.0
BIOEN,2022/12,4CB,Serbest Nakit Akım,Free Cash Flow,-21351651.0
BIOEN,2022/12,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,18991369.0
BIOEN,2022/12,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2022/12,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2022/12,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-5182502.0
BIOEN,2022/12,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,13808868.0
BIOEN,2022/12,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,-7542783.0
BIOEN,2022/12,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,-17655661.0
BIOEN,2022/12,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2022/12,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,-25198444.0
BIOEN,2022/12,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2022/12,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,27939512.0
BIOEN,2022/12,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,2741068.0
BIOEN,2022/3,1A,Dönen Varlıklar,CURRENT ASSETS,46117107.0
BIOEN,2022/3,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,7233562.0
BIOEN,2022/3,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2022/3,1AC,Ticari Alacaklar,Short-Term Trade Receivables,14247231.0
BIOEN,2022/3,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2022/3,1AE,Diğer Alacaklar,Short-Term Other Receivables,1396331.0
BIOEN,2022/3,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2022/3,1AF,Stoklar,Inventories,5033715.0
BIOEN,2022/3,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2022/3,1AH,Diğer Dönen Varlıklar,Other Current Assets,18206267.0
BIOEN,2022/3,1AI,(Ara Toplam),(Subtotal),46117107.0
BIOEN,2022/3,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2022/3,1AK,Duran Varlıklar,LONG TERM ASSETS,84748552.0
BIOEN,2022/3,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2022/3,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2022/3,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2022/3,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2022/3,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2022/3,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,3668850.0
BIOEN,2022/3,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2022/3,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,224493.0
BIOEN,2022/3,1BFA,Stoklar,Stoklar,0.0
BIOEN,2022/3,1BFAA,Kullanım Hakkı Varlıkları,nan,4946395.0
BIOEN,2022/3,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,67290390.0
BIOEN,2022/3,1BGA,Şerefiye,Goodwill,445460.0
BIOEN,2022/3,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,3653037.0
BIOEN,2022/3,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2022/3,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,4519928.0
BIOEN,2022/3,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,130865659.0
BIOEN,2022/3,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2022/3,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,36891543.0
BIOEN,2022/3,2AA,Finansal Borçlar,Short-Term Financial Loans,15837958.0
BIOEN,2022/3,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2022/3,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,16370146.0
BIOEN,2022/3,2AAGAB,Diğer Borçlar,Other Short-Term Loans,3164552.0
BIOEN,2022/3,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2022/3,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2022/3,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2022/3,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,143979.0
BIOEN,2022/3,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),0.0
BIOEN,2022/3,2AAGE,Borç Karşılıkları,Short-Term Provisions,881616.0
BIOEN,2022/3,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,493291.0
BIOEN,2022/3,2AAGG,(Ara Toplam),(Subtotal),36891543.0
BIOEN,2022/3,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2022/3,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,57678033.0
BIOEN,2022/3,2BA,Finansal Borçlar,Long-Term Financial Loans,56544496.0
BIOEN,2022/3,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2022/3,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2022/3,2BBB,Diğer Borçlar,Other Long-Term Loans,120546.0
BIOEN,2022/3,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2022/3,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2022/3,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2022/3,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2022/3,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,179417.0
BIOEN,2022/3,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2022/3,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,833575.0
BIOEN,2022/3,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2022/3,2N,Özkaynaklar,SHAREHOLDERS EQUITY,36296083.0
BIOEN,2022/3,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,36583699.0
BIOEN,2022/3,2OA,Ödenmiş Sermaye,Share Capital,34098271.0
BIOEN,2022/3,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2022/3,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,0.0
BIOEN,2022/3,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2022/3,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2022/3,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2022/3,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),2816814.0
BIOEN,2022/3,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),690636.0
BIOEN,2022/3,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,-1022022.0
BIOEN,2022/3,2ODA,Azınlık Payları,Minority Interests,-287616.0
BIOEN,2022/3,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,130865659.0
BIOEN,2022/3,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2022/3,3C,Satış Gelirleri,Net Sales,16920698.0
BIOEN,2022/3,3CA,Satışların Maliyeti (-),Cost Of Sales,-12044551.0
BIOEN,2022/3,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2022/3,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,4876147.0
BIOEN,2022/3,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2022/3,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2022/3,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2022/3,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2022/3,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2022/3,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),4876147.0
BIOEN,2022/3,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-33938.0
BIOEN,2022/3,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-1157526.0
BIOEN,2022/3,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2022/3,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,1232375.0
BIOEN,2022/3,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-2073568.0
BIOEN,2022/3,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2022/3,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,2843489.0
BIOEN,2022/3,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,3684683.0
BIOEN,2022/3,3HA,Yatırım Faaliyetlerinden Gelirler,nan,44446.0
BIOEN,2022/3,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2022/3,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2022/3,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,197044.0
BIOEN,2022/3,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,3084980.0
BIOEN,2022/3,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),2226618.0
BIOEN,2022/3,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-4437579.0
BIOEN,2022/3,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,44446.0
BIOEN,2022/3,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,874019.0
BIOEN,2022/3,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-256372.0
BIOEN,2022/3,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),0.0
BIOEN,2022/3,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-256372.0
BIOEN,2022/3,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2022/3,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,617647.0
BIOEN,2022/3,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2022/3,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2022/3,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,617647.0
BIOEN,2022/3,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2022/3,3LB,Azınlık Payları,Minority Interests,-107134.0
BIOEN,2022/3,3Z,Ana Ortaklık Payları,Parent Shares,724781.0
BIOEN,2022/3,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2022/3,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2022/3,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2022/3,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2022/3,4B,Amortisman Giderleri,Depreciation & Amortization,1600168.0
BIOEN,2022/3,4BA,Kıdem Tazminatı,Severance Payments,22467.0
BIOEN,2022/3,4BB,Finansman Giderleri,Financial Expenses,-4437579.0
BIOEN,2022/3,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2022/3,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2022/3,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-50692572.0
BIOEN,2022/3,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-65265617.0
BIOEN,2022/3,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-50692572.0
BIOEN,2022/3,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,-2286690.0
BIOEN,2022/3,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,617647.0
BIOEN,2022/3,4CAA,Düzeltmeler:,Adjustments:,767825.0
BIOEN,2022/3,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,1600168.0
BIOEN,2022/3,4CAC,Karşılıklardaki Değişim,Change in Provisions,191500.0
BIOEN,2022/3,4CAD,Diğer Gelir/ Gider,Other Income / Expense,-1023843.0
BIOEN,2022/3,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),1385472.0
BIOEN,2022/3,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-3438022.0
BIOEN,2022/3,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),-2052550.0
BIOEN,2022/3,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-234140.0
BIOEN,2022/3,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-8095140.0
BIOEN,2022/3,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,0.0
BIOEN,2022/3,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-8095140.0
BIOEN,2022/3,4CB,Serbest Nakit Akım,Free Cash Flow,-10381830.0
BIOEN,2022/3,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,6650558.0
BIOEN,2022/3,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2022/3,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2022/3,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-906129.0
BIOEN,2022/3,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,5744429.0
BIOEN,2022/3,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,-4637401.0
BIOEN,2022/3,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2022/3,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2022/3,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,-4637401.0
BIOEN,2022/3,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2022/3,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,12228591.0
BIOEN,2022/3,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,7591190.0
BIOEN,2022/6,1A,Dönen Varlıklar,CURRENT ASSETS,41398158.0
BIOEN,2022/6,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,4347617.0
BIOEN,2022/6,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2022/6,1AC,Ticari Alacaklar,Short-Term Trade Receivables,8461683.0
BIOEN,2022/6,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2022/6,1AE,Diğer Alacaklar,Short-Term Other Receivables,780516.0
BIOEN,2022/6,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2022/6,1AF,Stoklar,Inventories,5710173.0
BIOEN,2022/6,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2022/6,1AH,Diğer Dönen Varlıklar,Other Current Assets,22098168.0
BIOEN,2022/6,1AI,(Ara Toplam),(Subtotal),41398158.0
BIOEN,2022/6,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2022/6,1AK,Duran Varlıklar,LONG TERM ASSETS,81613529.0
BIOEN,2022/6,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2022/6,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2022/6,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2022/6,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2022/6,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2022/6,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,3216083.0
BIOEN,2022/6,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2022/6,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,620439.0
BIOEN,2022/6,1BFA,Stoklar,Stoklar,0.0
BIOEN,2022/6,1BFAA,Kullanım Hakkı Varlıkları,nan,4283346.0
BIOEN,2022/6,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,65362412.0
BIOEN,2022/6,1BGA,Şerefiye,Goodwill,391339.0
BIOEN,2022/6,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,3125708.0
BIOEN,2022/6,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2022/6,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,4614201.0
BIOEN,2022/6,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,123011687.0
BIOEN,2022/6,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2022/6,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,33197129.0
BIOEN,2022/6,2AA,Finansal Borçlar,Short-Term Financial Loans,17379141.0
BIOEN,2022/6,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2022/6,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,11804933.0
BIOEN,2022/6,2AAGAB,Diğer Borçlar,Other Short-Term Loans,2125952.0
BIOEN,2022/6,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2022/6,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2022/6,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2022/6,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,229361.0
BIOEN,2022/6,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),514394.0
BIOEN,2022/6,2AAGE,Borç Karşılıkları,Short-Term Provisions,676061.0
BIOEN,2022/6,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,467287.0
BIOEN,2022/6,2AAGG,(Ara Toplam),(Subtotal),33197129.0
BIOEN,2022/6,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2022/6,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,59355430.0
BIOEN,2022/6,2BA,Finansal Borçlar,Long-Term Financial Loans,57910490.0
BIOEN,2022/6,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2022/6,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2022/6,2BBB,Diğer Borçlar,Other Long-Term Loans,79425.0
BIOEN,2022/6,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2022/6,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2022/6,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2022/6,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2022/6,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,197040.0
BIOEN,2022/6,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2022/6,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,1168475.0
BIOEN,2022/6,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2022/6,2N,Özkaynaklar,SHAREHOLDERS EQUITY,30459128.0
BIOEN,2022/6,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,30459128.0
BIOEN,2022/6,2OA,Ödenmiş Sermaye,Share Capital,29955546.0
BIOEN,2022/6,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2022/6,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,1590123.0
BIOEN,2022/6,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2022/6,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2022/6,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2022/6,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),2796176.0
BIOEN,2022/6,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),1287658.0
BIOEN,2022/6,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,-5170375.0
BIOEN,2022/6,2ODA,Azınlık Payları,Minority Interests,0.0
BIOEN,2022/6,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,123011687.0
BIOEN,2022/6,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2022/6,3C,Satış Gelirleri,Net Sales,35042197.0
BIOEN,2022/6,3CA,Satışların Maliyeti (-),Cost Of Sales,-24784535.0
BIOEN,2022/6,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2022/6,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,10257663.0
BIOEN,2022/6,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2022/6,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2022/6,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2022/6,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2022/6,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2022/6,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),10257663.0
BIOEN,2022/6,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-115743.0
BIOEN,2022/6,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-2357736.0
BIOEN,2022/6,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2022/6,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,5829868.0
BIOEN,2022/6,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-3889401.0
BIOEN,2022/6,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2022/6,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,9724651.0
BIOEN,2022/6,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,7784184.0
BIOEN,2022/6,3HA,Yatırım Faaliyetlerinden Gelirler,nan,83435.0
BIOEN,2022/6,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2022/6,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2022/6,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,177072.0
BIOEN,2022/6,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,9985158.0
BIOEN,2022/6,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),5278923.0
BIOEN,2022/6,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-11983272.0
BIOEN,2022/6,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,83435.0
BIOEN,2022/6,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,3280810.0
BIOEN,2022/6,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-1837039.0
BIOEN,2022/6,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-808934.0
BIOEN,2022/6,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-1028105.0
BIOEN,2022/6,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2022/6,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,1443771.0
BIOEN,2022/6,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2022/6,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2022/6,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,1443771.0
BIOEN,2022/6,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2022/6,3LB,Azınlık Payları,Minority Interests,0.0
BIOEN,2022/6,3Z,Ana Ortaklık Payları,Parent Shares,1443771.0
BIOEN,2022/6,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2022/6,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2022/6,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2022/6,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2022/6,4B,Amortisman Giderleri,Depreciation & Amortization,3067685.0
BIOEN,2022/6,4BA,Kıdem Tazminatı,Severance Payments,44816.0
BIOEN,2022/6,4BB,Finansman Giderleri,Financial Expenses,-11983272.0
BIOEN,2022/6,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2022/6,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2022/6,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-57383070.0
BIOEN,2022/6,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-72726173.0
BIOEN,2022/6,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-57383070.0
BIOEN,2022/6,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,-7094589.0
BIOEN,2022/6,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,1443771.0
BIOEN,2022/6,4CAA,Düzeltmeler:,Adjustments:,3686506.0
BIOEN,2022/6,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,3067685.0
BIOEN,2022/6,4CAC,Karşılıklardaki Değişim,Change in Provisions,94045.0
BIOEN,2022/6,4CAD,Diğer Gelir/ Gider,Other Income / Expense,524776.0
BIOEN,2022/6,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),5130277.0
BIOEN,2022/6,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-11772924.0
BIOEN,2022/6,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),-6642647.0
BIOEN,2022/6,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-451942.0
BIOEN,2022/6,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-16033373.0
BIOEN,2022/6,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,-1482026.0
BIOEN,2022/6,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-17515399.0
BIOEN,2022/6,4CB,Serbest Nakit Akım,Free Cash Flow,-24609987.0
BIOEN,2022/6,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,19431707.0
BIOEN,2022/6,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2022/6,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2022/6,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-1424878.0
BIOEN,2022/6,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,18006830.0
BIOEN,2022/6,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,-6603158.0
BIOEN,2022/6,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2022/6,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2022/6,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,-6603158.0
BIOEN,2022/6,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2022/6,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,11477869.0
BIOEN,2022/6,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,4874711.0
BIOEN,2022/9,1A,Dönen Varlıklar,CURRENT ASSETS,56944341.0
BIOEN,2022/9,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,0.0
BIOEN,2022/9,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2022/9,1AC,Ticari Alacaklar,Short-Term Trade Receivables,11508697.0
BIOEN,2022/9,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2022/9,1AE,Diğer Alacaklar,Short-Term Other Receivables,527631.0
BIOEN,2022/9,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2022/9,1AF,Stoklar,Inventories,5703388.0
BIOEN,2022/9,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2022/9,1AH,Diğer Dönen Varlıklar,Other Current Assets,39204624.0
BIOEN,2022/9,1AI,(Ara Toplam),(Subtotal),56944341.0
BIOEN,2022/9,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2022/9,1AK,Duran Varlıklar,LONG TERM ASSETS,85630362.0
BIOEN,2022/9,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2022/9,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2022/9,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2022/9,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2022/9,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2022/9,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,3297057.0
BIOEN,2022/9,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2022/9,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,558212.0
BIOEN,2022/9,1BFA,Stoklar,Stoklar,0.0
BIOEN,2022/9,1BFAA,Kullanım Hakkı Varlıkları,nan,3801670.0
BIOEN,2022/9,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,70310988.0
BIOEN,2022/9,1BGA,Şerefiye,Goodwill,352090.0
BIOEN,2022/9,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,2736801.0
BIOEN,2022/9,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,0.0
BIOEN,2022/9,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,4573545.0
BIOEN,2022/9,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,142574703.0
BIOEN,2022/9,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2022/9,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,52687289.0
BIOEN,2022/9,2AA,Finansal Borçlar,Short-Term Financial Loans,20097572.0
BIOEN,2022/9,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2022/9,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,25175920.0
BIOEN,2022/9,2AAGAB,Diğer Borçlar,Other Short-Term Loans,1724959.0
BIOEN,2022/9,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2022/9,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2022/9,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2022/9,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,3956004.0
BIOEN,2022/9,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),588157.0
BIOEN,2022/9,2AAGE,Borç Karşılıkları,Short-Term Provisions,623837.0
BIOEN,2022/9,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,520840.0
BIOEN,2022/9,2AAGG,(Ara Toplam),(Subtotal),52687289.0
BIOEN,2022/9,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2022/9,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,63336387.0
BIOEN,2022/9,2BA,Finansal Borçlar,Long-Term Financial Loans,62544842.0
BIOEN,2022/9,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2022/9,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2022/9,2BBB,Diğer Borçlar,Other Long-Term Loans,23820.0
BIOEN,2022/9,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2022/9,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2022/9,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2022/9,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2022/9,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,181523.0
BIOEN,2022/9,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2022/9,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2022/9,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,586203.0
BIOEN,2022/9,2N,Özkaynaklar,SHAREHOLDERS EQUITY,26551027.0
BIOEN,2022/9,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,26551027.0
BIOEN,2022/9,2OA,Ödenmiş Sermaye,Share Capital,26951127.0
BIOEN,2022/9,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2022/9,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,1430640.0
BIOEN,2022/9,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2022/9,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2022/9,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2022/9,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),2515731.0
BIOEN,2022/9,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),4521971.0
BIOEN,2022/9,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,-8868441.0
BIOEN,2022/9,2ODA,Azınlık Payları,Minority Interests,0.0
BIOEN,2022/9,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,142574703.0
BIOEN,2022/9,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2022/9,3C,Satış Gelirleri,Net Sales,51689730.0
BIOEN,2022/9,3CA,Satışların Maliyeti (-),Cost Of Sales,-37021245.0
BIOEN,2022/9,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2022/9,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,14668485.0
BIOEN,2022/9,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2022/9,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2022/9,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2022/9,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2022/9,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2022/9,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),14668485.0
BIOEN,2022/9,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-210380.0
BIOEN,2022/9,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-4016566.0
BIOEN,2022/9,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2022/9,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,6439145.0
BIOEN,2022/9,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-3994120.0
BIOEN,2022/9,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2022/9,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,12886565.0
BIOEN,2022/9,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,10441539.0
BIOEN,2022/9,3HA,Yatırım Faaliyetlerinden Gelirler,nan,78053.0
BIOEN,2022/9,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,0.0
BIOEN,2022/9,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2022/9,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,636103.0
BIOEN,2022/9,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,13600721.0
BIOEN,2022/9,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),6635075.0
BIOEN,2022/9,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-11963726.0
BIOEN,2022/9,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,78053.0
BIOEN,2022/9,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,8272070.0
BIOEN,2022/9,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-3000193.0
BIOEN,2022/9,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-1351797.0
BIOEN,2022/9,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-1648396.0
BIOEN,2022/9,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2022/9,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,5271877.0
BIOEN,2022/9,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2022/9,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2022/9,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,5271877.0
BIOEN,2022/9,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2022/9,3LB,Azınlık Payları,Minority Interests,0.0
BIOEN,2022/9,3Z,Ana Ortaklık Payları,Parent Shares,5271877.0
BIOEN,2022/9,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2022/9,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2022/9,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2022/9,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2022/9,4B,Amortisman Giderleri,Depreciation & Amortization,4397162.0
BIOEN,2022/9,4BA,Kıdem Tazminatı,Severance Payments,61820.0
BIOEN,2022/9,4BB,Finansman Giderleri,Financial Expenses,-11963726.0
BIOEN,2022/9,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2022/9,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2022/9,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-72776640.0
BIOEN,2022/9,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-93260384.0
BIOEN,2022/9,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-72776640.0
BIOEN,2022/9,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,-5277836.0
BIOEN,2022/9,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,5271877.0
BIOEN,2022/9,4CAA,Düzeltmeler:,Adjustments:,2247688.0
BIOEN,2022/9,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,4397162.0
BIOEN,2022/9,4CAC,Karşılıklardaki Değişim,Change in Provisions,126931.0
BIOEN,2022/9,4CAD,Diğer Gelir/ Gider,Other Income / Expense,-2276405.0
BIOEN,2022/9,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),7519565.0
BIOEN,2022/9,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-11925709.0
BIOEN,2022/9,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),-4406144.0
BIOEN,2022/9,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-871692.0
BIOEN,2022/9,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-29850493.0
BIOEN,2022/9,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,-1386422.0
BIOEN,2022/9,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-31236915.0
BIOEN,2022/9,4CB,Serbest Nakit Akım,Free Cash Flow,-36514751.0
BIOEN,2022/9,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,35614550.0
BIOEN,2022/9,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2022/9,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2022/9,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-3185915.0
BIOEN,2022/9,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,32428635.0
BIOEN,2022/9,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,-4086116.0
BIOEN,2022/9,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2022/9,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2022/9,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,-4086116.0
BIOEN,2022/9,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2022/9,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,10737443.0
BIOEN,2022/9,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,6651326.0
BIOEN,2023/12,1A,Dönen Varlıklar,CURRENT ASSETS,56098317.0
BIOEN,2023/12,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,7205561.0
BIOEN,2023/12,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2023/12,1AC,Ticari Alacaklar,Short-Term Trade Receivables,12205485.0
BIOEN,2023/12,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2023/12,1AE,Diğer Alacaklar,Short-Term Other Receivables,1092449.0
BIOEN,2023/12,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2023/12,1AF,Stoklar,Inventories,15940663.0
BIOEN,2023/12,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2023/12,1AH,Diğer Dönen Varlıklar,Other Current Assets,19654160.0
BIOEN,2023/12,1AI,(Ara Toplam),(Subtotal),56098317.0
BIOEN,2023/12,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2023/12,1AK,Duran Varlıklar,LONG TERM ASSETS,270352698.0
BIOEN,2023/12,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2023/12,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2023/12,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2023/12,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2023/12,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2023/12,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,13771354.0
BIOEN,2023/12,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2023/12,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,1630053.0
BIOEN,2023/12,1BFA,Stoklar,Stoklar,0.0
BIOEN,2023/12,1BFAA,Kullanım Hakkı Varlıkları,nan,5727326.0
BIOEN,2023/12,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,226408548.0
BIOEN,2023/12,1BGA,Şerefiye,Goodwill,1894349.0
BIOEN,2023/12,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,12117756.0
BIOEN,2023/12,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,8803312.0
BIOEN,2023/12,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2023/12,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,326451015.0
BIOEN,2023/12,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2023/12,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,78538365.0
BIOEN,2023/12,2AA,Finansal Borçlar,Short-Term Financial Loans,44969337.0
BIOEN,2023/12,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2023/12,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,27872341.0
BIOEN,2023/12,2AAGAB,Diğer Borçlar,Other Short-Term Loans,3154860.0
BIOEN,2023/12,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2023/12,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2023/12,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2023/12,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,219769.0
BIOEN,2023/12,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),17169.0
BIOEN,2023/12,2AAGE,Borç Karşılıkları,Short-Term Provisions,765412.0
BIOEN,2023/12,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1539477.0
BIOEN,2023/12,2AAGG,(Ara Toplam),(Subtotal),78538365.0
BIOEN,2023/12,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2023/12,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,108323500.0
BIOEN,2023/12,2BA,Finansal Borçlar,Long-Term Financial Loans,107794013.0
BIOEN,2023/12,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2023/12,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2023/12,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2023/12,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2023/12,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2023/12,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2023/12,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2023/12,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,529488.0
BIOEN,2023/12,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2023/12,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2023/12,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2023/12,2N,Özkaynaklar,SHAREHOLDERS EQUITY,139589150.0
BIOEN,2023/12,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,138997061.0
BIOEN,2023/12,2OA,Ödenmiş Sermaye,Share Capital,16954153.0
BIOEN,2023/12,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2023/12,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,5161355.0
BIOEN,2023/12,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2023/12,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2023/12,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,958568.0
BIOEN,2023/12,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),46701685.0
BIOEN,2023/12,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),46416686.0
BIOEN,2023/12,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,22804614.0
BIOEN,2023/12,2ODA,Azınlık Payları,Minority Interests,592089.0
BIOEN,2023/12,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,326451015.0
BIOEN,2023/12,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2023/12,3C,Satış Gelirleri,Net Sales,135300783.0
BIOEN,2023/12,3CA,Satışların Maliyeti (-),Cost Of Sales,-114804016.0
BIOEN,2023/12,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2023/12,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,20496767.0
BIOEN,2023/12,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2023/12,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2023/12,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2023/12,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2023/12,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2023/12,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),20496767.0
BIOEN,2023/12,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-112638.0
BIOEN,2023/12,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-19590870.0
BIOEN,2023/12,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2023/12,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,21844827.0
BIOEN,2023/12,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-13044425.0
BIOEN,2023/12,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2023/12,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,9593662.0
BIOEN,2023/12,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,793259.0
BIOEN,2023/12,3HA,Yatırım Faaliyetlerinden Gelirler,nan,564226.0
BIOEN,2023/12,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-509786.0
BIOEN,2023/12,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2023/12,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,5966908.0
BIOEN,2023/12,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,15615010.0
BIOEN,2023/12,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),10692592.0
BIOEN,2023/12,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),29926498.0
BIOEN,2023/12,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,54440.0
BIOEN,2023/12,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,56234100.0
BIOEN,2023/12,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,1333968.0
BIOEN,2023/12,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-53066.0
BIOEN,2023/12,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,1387034.0
BIOEN,2023/12,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2023/12,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,57568068.0
BIOEN,2023/12,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2023/12,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2023/12,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,57568068.0
BIOEN,2023/12,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2023/12,3LB,Azınlık Payları,Minority Interests,120625.0
BIOEN,2023/12,3Z,Ana Ortaklık Payları,Parent Shares,57447443.0
BIOEN,2023/12,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2023/12,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2023/12,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2023/12,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2023/12,4B,Amortisman Giderleri,Depreciation & Amortization,26817311.0
BIOEN,2023/12,4BA,Kıdem Tazminatı,Severance Payments,342041.0
BIOEN,2023/12,4BB,Finansman Giderleri,Financial Expenses,29926498.0
BIOEN,2023/12,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2023/12,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2023/12,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-113274546.0
BIOEN,2023/12,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-120527415.0
BIOEN,2023/12,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-113274546.0
BIOEN,2023/12,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,67617848.0
BIOEN,2023/12,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,57568068.0
BIOEN,2023/12,4CAA,Düzeltmeler:,Adjustments:,-15761393.0
BIOEN,2023/12,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,26817311.0
BIOEN,2023/12,4CAC,Karşılıklardaki Değişim,Change in Provisions,566331.0
BIOEN,2023/12,4CAD,Diğer Gelir/ Gider,Other Income / Expense,-41757811.0
BIOEN,2023/12,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),41806675.0
BIOEN,2023/12,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,25944269.0
BIOEN,2023/12,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),67750945.0
BIOEN,2023/12,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-133096.0
BIOEN,2023/12,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-62385159.0
BIOEN,2023/12,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,3214437.0
BIOEN,2023/12,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-59170722.0
BIOEN,2023/12,4CB,Serbest Nakit Akım,Free Cash Flow,8447126.0
BIOEN,2023/12,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,12437034.0
BIOEN,2023/12,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2023/12,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2023/12,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-13640937.0
BIOEN,2023/12,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,-1203903.0
BIOEN,2023/12,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,7243223.0
BIOEN,2023/12,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2023/12,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2023/12,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,7243223.0
BIOEN,2023/12,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2023/12,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,2759475.0
BIOEN,2023/12,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,8917937.0
BIOEN,2023/3,1A,Dönen Varlıklar,CURRENT ASSETS,68239432.0
BIOEN,2023/3,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,3841205.0
BIOEN,2023/3,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2023/3,1AC,Ticari Alacaklar,Short-Term Trade Receivables,19408321.0
BIOEN,2023/3,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2023/3,1AE,Diğer Alacaklar,Short-Term Other Receivables,584592.0
BIOEN,2023/3,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2023/3,1AF,Stoklar,Inventories,8356630.0
BIOEN,2023/3,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2023/3,1AH,Diğer Dönen Varlıklar,Other Current Assets,36048683.0
BIOEN,2023/3,1AI,(Ara Toplam),(Subtotal),68239432.0
BIOEN,2023/3,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2023/3,1AK,Duran Varlıklar,LONG TERM ASSETS,121783526.0
BIOEN,2023/3,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2023/3,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2023/3,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2023/3,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2023/3,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2023/3,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,5681661.0
BIOEN,2023/3,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2023/3,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,780444.0
BIOEN,2023/3,1BFA,Stoklar,Stoklar,0.0
BIOEN,2023/3,1BFAA,Kullanım Hakkı Varlıkları,nan,2962746.0
BIOEN,2023/3,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,101825833.0
BIOEN,2023/3,1BGA,Şerefiye,Goodwill,340425.0
BIOEN,2023/3,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,2302069.0
BIOEN,2023/3,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,7890348.0
BIOEN,2023/3,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2023/3,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,190022958.0
BIOEN,2023/3,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2023/3,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,74857023.0
BIOEN,2023/3,2AA,Finansal Borçlar,Short-Term Financial Loans,27402773.0
BIOEN,2023/3,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2023/3,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,36797255.0
BIOEN,2023/3,2AAGAB,Diğer Borçlar,Other Short-Term Loans,8296386.0
BIOEN,2023/3,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2023/3,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2023/3,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2023/3,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,59927.0
BIOEN,2023/3,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),81214.0
BIOEN,2023/3,2AAGE,Borç Karşılıkları,Short-Term Provisions,1020442.0
BIOEN,2023/3,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1199026.0
BIOEN,2023/3,2AAGG,(Ara Toplam),(Subtotal),74857023.0
BIOEN,2023/3,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2023/3,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,76579041.0
BIOEN,2023/3,2BA,Finansal Borçlar,Long-Term Financial Loans,76020419.0
BIOEN,2023/3,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2023/3,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2023/3,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2023/3,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2023/3,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2023/3,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2023/3,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,159804.0
BIOEN,2023/3,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,398818.0
BIOEN,2023/3,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2023/3,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2023/3,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2023/3,2N,Özkaynaklar,SHAREHOLDERS EQUITY,38586894.0
BIOEN,2023/3,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,38294039.0
BIOEN,2023/3,2OA,Ödenmiş Sermaye,Share Capital,26058224.0
BIOEN,2023/3,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2023/3,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,1383242.0
BIOEN,2023/3,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2023/3,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2023/3,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2023/3,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),18642419.0
BIOEN,2023/3,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),3436152.0
BIOEN,2023/3,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,-11225998.0
BIOEN,2023/3,2ODA,Azınlık Payları,Minority Interests,292855.0
BIOEN,2023/3,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,190022958.0
BIOEN,2023/3,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2023/3,3C,Satış Gelirleri,Net Sales,34415643.0
BIOEN,2023/3,3CA,Satışların Maliyeti (-),Cost Of Sales,-25707131.0
BIOEN,2023/3,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2023/3,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,8708512.0
BIOEN,2023/3,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2023/3,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2023/3,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2023/3,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2023/3,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2023/3,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),8708512.0
BIOEN,2023/3,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-18258.0
BIOEN,2023/3,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-6605965.0
BIOEN,2023/3,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2023/3,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,5569174.0
BIOEN,2023/3,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-2235234.0
BIOEN,2023/3,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2023/3,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,5418228.0
BIOEN,2023/3,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,2084289.0
BIOEN,2023/3,3HA,Yatırım Faaliyetlerinden Gelirler,nan,45607.0
BIOEN,2023/3,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-617687.0
BIOEN,2023/3,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2023/3,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,280550.0
BIOEN,2023/3,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,5126698.0
BIOEN,2023/3,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),2067467.0
BIOEN,2023/3,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),17128541.0
BIOEN,2023/3,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,-572081.0
BIOEN,2023/3,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,24322706.0
BIOEN,2023/3,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-5180024.0
BIOEN,2023/3,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-292811.0
BIOEN,2023/3,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-4887213.0
BIOEN,2023/3,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2023/3,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,19142682.0
BIOEN,2023/3,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2023/3,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2023/3,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,19142682.0
BIOEN,2023/3,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2023/3,3LB,Azınlık Payları,Minority Interests,-21318.0
BIOEN,2023/3,3Z,Ana Ortaklık Payları,Parent Shares,19163999.0
BIOEN,2023/3,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2023/3,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2023/3,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2023/3,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2023/3,4B,Amortisman Giderleri,Depreciation & Amortization,5873435.0
BIOEN,2023/3,4BA,Kıdem Tazminatı,Severance Payments,0.0
BIOEN,2023/3,4BB,Finansman Giderleri,Financial Expenses,17128541.0
BIOEN,2023/3,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2023/3,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2023/3,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-80017128.0
BIOEN,2023/3,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-9411511.0
BIOEN,2023/3,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-80017128.0
BIOEN,2023/3,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,40419282.0
BIOEN,2023/3,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,17658545.0
BIOEN,2023/3,4CAA,Düzeltmeler:,Adjustments:,7381746.0
BIOEN,2023/3,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,5420264.0
BIOEN,2023/3,4CAC,Karşılıklardaki Değişim,Change in Provisions,326320.0
BIOEN,2023/3,4CAD,Diğer Gelir/ Gider,Other Income / Expense,1635161.0
BIOEN,2023/3,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),25040291.0
BIOEN,2023/3,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,15611925.0
BIOEN,2023/3,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),40652216.0
BIOEN,2023/3,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-232934.0
BIOEN,2023/3,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-30671326.0
BIOEN,2023/3,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,-5326886.0
BIOEN,2023/3,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-35998212.0
BIOEN,2023/3,4CB,Serbest Nakit Akım,Free Cash Flow,4421070.0
BIOEN,2023/3,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,3720638.0
BIOEN,2023/3,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2023/3,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2023/3,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-2801803.0
BIOEN,2023/3,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,918835.0
BIOEN,2023/3,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,5339905.0
BIOEN,2023/3,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,-308650.0
BIOEN,2023/3,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2023/3,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,5031255.0
BIOEN,2023/3,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2023/3,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,2773592.0
BIOEN,2023/3,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,7804847.0
BIOEN,2023/6,1A,Dönen Varlıklar,CURRENT ASSETS,47083492.0
BIOEN,2023/6,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,9976314.0
BIOEN,2023/6,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2023/6,1AC,Ticari Alacaklar,Short-Term Trade Receivables,14428585.0
BIOEN,2023/6,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2023/6,1AE,Diğer Alacaklar,Short-Term Other Receivables,1344024.0
BIOEN,2023/6,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2023/6,1AF,Stoklar,Inventories,6469633.0
BIOEN,2023/6,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2023/6,1AH,Diğer Dönen Varlıklar,Other Current Assets,14864935.0
BIOEN,2023/6,1AI,(Ara Toplam),(Subtotal),47083492.0
BIOEN,2023/6,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2023/6,1AK,Duran Varlıklar,LONG TERM ASSETS,97824944.0
BIOEN,2023/6,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2023/6,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2023/6,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2023/6,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2023/6,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2023/6,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,2231953.0
BIOEN,2023/6,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2023/6,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,578865.0
BIOEN,2023/6,1BFA,Stoklar,Stoklar,0.0
BIOEN,2023/6,1BFAA,Kullanım Hakkı Varlıkları,nan,2593506.0
BIOEN,2023/6,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,79427529.0
BIOEN,2023/6,1BGA,Şerefiye,Goodwill,252497.0
BIOEN,2023/6,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,1657848.0
BIOEN,2023/6,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,11082746.0
BIOEN,2023/6,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2023/6,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,144908436.0
BIOEN,2023/6,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2023/6,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,43716090.0
BIOEN,2023/6,2AA,Finansal Borçlar,Short-Term Financial Loans,31333564.0
BIOEN,2023/6,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2023/6,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,9626542.0
BIOEN,2023/6,2AAGAB,Diğer Borçlar,Other Short-Term Loans,907407.0
BIOEN,2023/6,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2023/6,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2023/6,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2023/6,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,148161.0
BIOEN,2023/6,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),1910.0
BIOEN,2023/6,2AAGE,Borç Karşılıkları,Short-Term Provisions,794889.0
BIOEN,2023/6,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,903617.0
BIOEN,2023/6,2AAGG,(Ara Toplam),(Subtotal),43716090.0
BIOEN,2023/6,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2023/6,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,83677822.0
BIOEN,2023/6,2BA,Finansal Borçlar,Long-Term Financial Loans,83308255.0
BIOEN,2023/6,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2023/6,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2023/6,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2023/6,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2023/6,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2023/6,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2023/6,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2023/6,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,369567.0
BIOEN,2023/6,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2023/6,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2023/6,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2023/6,2N,Özkaynaklar,SHAREHOLDERS EQUITY,17514524.0
BIOEN,2023/6,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,17291897.0
BIOEN,2023/6,2OA,Ödenmiş Sermaye,Share Capital,19327705.0
BIOEN,2023/6,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2023/6,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,1025968.0
BIOEN,2023/6,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2023/6,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2023/6,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2023/6,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),13827311.0
BIOEN,2023/6,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),6987825.0
BIOEN,2023/6,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,-23876911.0
BIOEN,2023/6,2ODA,Azınlık Payları,Minority Interests,222627.0
BIOEN,2023/6,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,144908436.0
BIOEN,2023/6,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2023/6,3C,Satış Gelirleri,Net Sales,67836520.0
BIOEN,2023/6,3CA,Satışların Maliyeti (-),Cost Of Sales,-55682622.0
BIOEN,2023/6,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2023/6,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,12153898.0
BIOEN,2023/6,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2023/6,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2023/6,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2023/6,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2023/6,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2023/6,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),12153898.0
BIOEN,2023/6,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-88054.0
BIOEN,2023/6,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-11261364.0
BIOEN,2023/6,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2023/6,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,14650865.0
BIOEN,2023/6,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-20816042.0
BIOEN,2023/6,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2023/6,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,-5360697.0
BIOEN,2023/6,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,804480.0
BIOEN,2023/6,3HA,Yatırım Faaliyetlerinden Gelirler,nan,43517.0
BIOEN,2023/6,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-441295.0
BIOEN,2023/6,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2023/6,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,1517128.0
BIOEN,2023/6,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,-4241348.0
BIOEN,2023/6,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),55980641.0
BIOEN,2023/6,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),20898489.0
BIOEN,2023/6,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,-397778.0
BIOEN,2023/6,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,72637782.0
BIOEN,2023/6,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-16260519.0
BIOEN,2023/6,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-4283.0
BIOEN,2023/6,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-16256236.0
BIOEN,2023/6,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2023/6,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,56377263.0
BIOEN,2023/6,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2023/6,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2023/6,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,56377263.0
BIOEN,2023/6,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2023/6,3LB,Azınlık Payları,Minority Interests,-149299.0
BIOEN,2023/6,3Z,Ana Ortaklık Payları,Parent Shares,56526562.0
BIOEN,2023/6,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2023/6,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2023/6,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2023/6,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2023/6,4B,Amortisman Giderleri,Depreciation & Amortization,12949640.0
BIOEN,2023/6,4BA,Kıdem Tazminatı,Severance Payments,104565.0
BIOEN,2023/6,4BB,Finansman Giderleri,Financial Expenses,20898489.0
BIOEN,2023/6,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2023/6,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2023/6,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-85769026.0
BIOEN,2023/6,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-95027958.0
BIOEN,2023/6,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-85769026.0
BIOEN,2023/6,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,29918135.0
BIOEN,2023/6,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,56377263.0
BIOEN,2023/6,4CAA,Düzeltmeler:,Adjustments:,-12401474.0
BIOEN,2023/6,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,12949640.0
BIOEN,2023/6,4CAC,Karşılıklardaki Değişim,Change in Provisions,331288.0
BIOEN,2023/6,4CAD,Diğer Gelir/ Gider,Other Income / Expense,-26355554.0
BIOEN,2023/6,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),43975789.0
BIOEN,2023/6,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-14595731.0
BIOEN,2023/6,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),29380058.0
BIOEN,2023/6,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,538077.0
BIOEN,2023/6,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-74545287.0
BIOEN,2023/6,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,-450669.0
BIOEN,2023/6,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-74995956.0
BIOEN,2023/6,4CB,Serbest Nakit Akım,Free Cash Flow,-45077821.0
BIOEN,2023/6,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,74530689.0
BIOEN,2023/6,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2023/6,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2023/6,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-9482246.0
BIOEN,2023/6,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,65048443.0
BIOEN,2023/6,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,19496973.0
BIOEN,2023/6,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2023/6,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2023/6,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,19496973.0
BIOEN,2023/6,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2023/6,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,2868960.0
BIOEN,2023/6,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,22365932.0
BIOEN,2023/9,1A,Dönen Varlıklar,CURRENT ASSETS,41456152.0
BIOEN,2023/9,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,7570018.0
BIOEN,2023/9,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2023/9,1AC,Ticari Alacaklar,Short-Term Trade Receivables,15385786.0
BIOEN,2023/9,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2023/9,1AE,Diğer Alacaklar,Short-Term Other Receivables,537342.0
BIOEN,2023/9,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2023/9,1AF,Stoklar,Inventories,7854810.0
BIOEN,2023/9,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2023/9,1AH,Diğer Dönen Varlıklar,Other Current Assets,10108196.0
BIOEN,2023/9,1AI,(Ara Toplam),(Subtotal),41456152.0
BIOEN,2023/9,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2023/9,1AK,Duran Varlıklar,LONG TERM ASSETS,107861446.0
BIOEN,2023/9,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2023/9,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2023/9,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2023/9,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2023/9,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2023/9,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,3274540.0
BIOEN,2023/9,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2023/9,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,546015.0
BIOEN,2023/9,1BFA,Stoklar,Stoklar,0.0
BIOEN,2023/9,1BFAA,Kullanım Hakkı Varlıkları,nan,2161036.0
BIOEN,2023/9,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,83421915.0
BIOEN,2023/9,1BGA,Şerefiye,Goodwill,238168.0
BIOEN,2023/9,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,1571473.0
BIOEN,2023/9,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,16648298.0
BIOEN,2023/9,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2023/9,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,149317597.0
BIOEN,2023/9,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2023/9,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,46822587.0
BIOEN,2023/9,2AA,Finansal Borçlar,Short-Term Financial Loans,30039668.0
BIOEN,2023/9,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2023/9,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,13539086.0
BIOEN,2023/9,2AAGAB,Diğer Borçlar,Other Short-Term Loans,1188180.0
BIOEN,2023/9,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2023/9,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2023/9,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2023/9,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,125778.0
BIOEN,2023/9,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),0.0
BIOEN,2023/9,2AAGE,Borç Karşılıkları,Short-Term Provisions,640327.0
BIOEN,2023/9,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1289549.0
BIOEN,2023/9,2AAGG,(Ara Toplam),(Subtotal),46822587.0
BIOEN,2023/9,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2023/9,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,81284631.0
BIOEN,2023/9,2BA,Finansal Borçlar,Long-Term Financial Loans,80911072.0
BIOEN,2023/9,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2023/9,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2023/9,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2023/9,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2023/9,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2023/9,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2023/9,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2023/9,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,373559.0
BIOEN,2023/9,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2023/9,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2023/9,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2023/9,2N,Özkaynaklar,SHAREHOLDERS EQUITY,21210380.0
BIOEN,2023/9,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,20999108.0
BIOEN,2023/9,2OA,Ödenmiş Sermaye,Share Capital,18230876.0
BIOEN,2023/9,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2023/9,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,967745.0
BIOEN,2023/9,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2023/9,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2023/9,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,0.0
BIOEN,2023/9,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),13042624.0
BIOEN,2023/9,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),12899142.0
BIOEN,2023/9,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,-24141279.0
BIOEN,2023/9,2ODA,Azınlık Payları,Minority Interests,211272.0
BIOEN,2023/9,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,149317597.0
BIOEN,2023/9,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2023/9,3C,Satış Gelirleri,Net Sales,104993919.0
BIOEN,2023/9,3CA,Satışların Maliyeti (-),Cost Of Sales,-92102179.0
BIOEN,2023/9,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2023/9,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,12891739.0
BIOEN,2023/9,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2023/9,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2023/9,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2023/9,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2023/9,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2023/9,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),12891739.0
BIOEN,2023/9,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-96889.0
BIOEN,2023/9,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-11171575.0
BIOEN,2023/9,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2023/9,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,21253065.0
BIOEN,2023/9,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-5780481.0
BIOEN,2023/9,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2023/9,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,17095859.0
BIOEN,2023/9,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,1623275.0
BIOEN,2023/9,3HA,Yatırım Faaliyetlerinden Gelirler,nan,42278.0
BIOEN,2023/9,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-428771.0
BIOEN,2023/9,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2023/9,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,502756.0
BIOEN,2023/9,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,17212122.0
BIOEN,2023/9,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),7740085.0
BIOEN,2023/9,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),26738233.0
BIOEN,2023/9,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,-386493.0
BIOEN,2023/9,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,51690440.0
BIOEN,2023/9,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-21647118.0
BIOEN,2023/9,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),0.0
BIOEN,2023/9,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-21647118.0
BIOEN,2023/9,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2023/9,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,30043322.0
BIOEN,2023/9,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2023/9,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2023/9,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,30043322.0
BIOEN,2023/9,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2023/9,3LB,Azınlık Payları,Minority Interests,-543436.0
BIOEN,2023/9,3Z,Ana Ortaklık Payları,Parent Shares,30586758.0
BIOEN,2023/9,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2023/9,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2023/9,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2023/9,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2023/9,4B,Amortisman Giderleri,Depreciation & Amortization,19027967.0
BIOEN,2023/9,4BA,Kıdem Tazminatı,Severance Payments,345488.0
BIOEN,2023/9,4BB,Finansman Giderleri,Financial Expenses,26738233.0
BIOEN,2023/9,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2023/9,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2023/9,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-79442285.0
BIOEN,2023/9,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-86798101.0
BIOEN,2023/9,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-79442285.0
BIOEN,2023/9,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,45751886.0
BIOEN,2023/9,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,30043322.0
BIOEN,2023/9,4CAA,Düzeltmeler:,Adjustments:,11751596.0
BIOEN,2023/9,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,19027967.0
BIOEN,2023/9,4CAC,Karşılıklardaki Değişim,Change in Provisions,235631.0
BIOEN,2023/9,4CAD,Diğer Gelir/ Gider,Other Income / Expense,-6295332.0
BIOEN,2023/9,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),41794917.0
BIOEN,2023/9,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,3441687.0
BIOEN,2023/9,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),45236604.0
BIOEN,2023/9,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,515282.0
BIOEN,2023/9,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-48283994.0
BIOEN,2023/9,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,2547774.0
BIOEN,2023/9,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-45736220.0
BIOEN,2023/9,4CB,Serbest Nakit Akım,Free Cash Flow,15666.0
BIOEN,2023/9,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,30770591.0
BIOEN,2023/9,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2023/9,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2023/9,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-16438652.0
BIOEN,2023/9,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,14331939.0
BIOEN,2023/9,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,13420308.0
BIOEN,2023/9,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2023/9,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2023/9,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,13420308.0
BIOEN,2023/9,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2023/9,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,2787280.0
BIOEN,2023/9,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,16207588.0
BIOEN,2024/12,1A,Dönen Varlıklar,CURRENT ASSETS,39360378.0
BIOEN,2024/12,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,3498067.0
BIOEN,2024/12,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2024/12,1AC,Ticari Alacaklar,Short-Term Trade Receivables,6461926.0
BIOEN,2024/12,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2024/12,1AE,Diğer Alacaklar,Short-Term Other Receivables,1165453.0
BIOEN,2024/12,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2024/12,1AF,Stoklar,Inventories,13540453.0
BIOEN,2024/12,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2024/12,1AH,Diğer Dönen Varlıklar,Other Current Assets,14694478.0
BIOEN,2024/12,1AI,(Ara Toplam),(Subtotal),39360378.0
BIOEN,2024/12,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2024/12,1AK,Duran Varlıklar,LONG TERM ASSETS,265514335.0
BIOEN,2024/12,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2024/12,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2024/12,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2024/12,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2024/12,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2024/12,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,11318033.0
BIOEN,2024/12,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2024/12,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,635067.0
BIOEN,2024/12,1BFA,Stoklar,Stoklar,0.0
BIOEN,2024/12,1BFAA,Kullanım Hakkı Varlıkları,nan,6749797.0
BIOEN,2024/12,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,221374093.0
BIOEN,2024/12,1BGA,Şerefiye,Goodwill,1982626.0
BIOEN,2024/12,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,14402182.0
BIOEN,2024/12,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,9052537.0
BIOEN,2024/12,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2024/12,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,304874713.0
BIOEN,2024/12,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2024/12,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,61787359.0
BIOEN,2024/12,2AA,Finansal Borçlar,Short-Term Financial Loans,40366033.0
BIOEN,2024/12,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2024/12,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,13461969.0
BIOEN,2024/12,2AAGAB,Diğer Borçlar,Other Short-Term Loans,5560401.0
BIOEN,2024/12,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2024/12,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2024/12,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2024/12,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,238921.0
BIOEN,2024/12,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),147390.0
BIOEN,2024/12,2AAGE,Borç Karşılıkları,Short-Term Provisions,722602.0
BIOEN,2024/12,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1290044.0
BIOEN,2024/12,2AAGG,(Ara Toplam),(Subtotal),61787359.0
BIOEN,2024/12,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2024/12,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,100707487.0
BIOEN,2024/12,2BA,Finansal Borçlar,Long-Term Financial Loans,99911039.0
BIOEN,2024/12,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2024/12,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2024/12,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2024/12,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2024/12,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2024/12,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2024/12,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2024/12,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,796447.0
BIOEN,2024/12,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2024/12,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2024/12,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2024/12,2N,Özkaynaklar,SHAREHOLDERS EQUITY,142379867.0
BIOEN,2024/12,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,142025508.0
BIOEN,2024/12,2OA,Ödenmiş Sermaye,Share Capital,14146753.0
BIOEN,2024/12,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2024/12,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,5401873.0
BIOEN,2024/12,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2024/12,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2024/12,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,1003238.0
BIOEN,2024/12,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),94412296.0
BIOEN,2024/12,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),3499001.0
BIOEN,2024/12,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,19964887.0
BIOEN,2024/12,2ODA,Azınlık Payları,Minority Interests,354359.0
BIOEN,2024/12,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,304874713.0
BIOEN,2024/12,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2024/12,3C,Satış Gelirleri,Net Sales,102550149.0
BIOEN,2024/12,3CA,Satışların Maliyeti (-),Cost Of Sales,-98012602.0
BIOEN,2024/12,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2024/12,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,4537547.0
BIOEN,2024/12,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2024/12,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2024/12,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2024/12,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2024/12,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2024/12,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),4537547.0
BIOEN,2024/12,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-210932.0
BIOEN,2024/12,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-18300977.0
BIOEN,2024/12,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2024/12,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,4272572.0
BIOEN,2024/12,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-4182846.0
BIOEN,2024/12,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2024/12,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,-13884635.0
BIOEN,2024/12,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,-13974362.0
BIOEN,2024/12,3HA,Yatırım Faaliyetlerinden Gelirler,nan,10255290.0
BIOEN,2024/12,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-791.0
BIOEN,2024/12,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2024/12,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,-3991359.0
BIOEN,2024/12,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,-7621495.0
BIOEN,2024/12,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),2631171.0
BIOEN,2024/12,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),10228728.0
BIOEN,2024/12,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,10254499.0
BIOEN,2024/12,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,5238404.0
BIOEN,2024/12,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-1476436.0
BIOEN,2024/12,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-179658.0
BIOEN,2024/12,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-1296778.0
BIOEN,2024/12,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2024/12,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,3761968.0
BIOEN,2024/12,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2024/12,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,3761968.0
BIOEN,2024/12,3LB,Azınlık Payları,Minority Interests,0.0
BIOEN,2024/12,3Z,Ana Ortaklık Payları,Parent Shares,3761968.0
BIOEN,2024/12,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2024/12,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2024/12,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2024/12,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2024/12,4B,Amortisman Giderleri,Depreciation & Amortization,27440744.0
BIOEN,2024/12,4BA,Kıdem Tazminatı,Severance Payments,253573.0
BIOEN,2024/12,4BB,Finansman Giderleri,Financial Expenses,10228728.0
BIOEN,2024/12,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2024/12,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2024/12,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,158706412.0
BIOEN,2024/12,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,158706412.0
BIOEN,2024/12,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),158706412.0
BIOEN,2024/12,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,50516971.0
BIOEN,2024/12,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,3761968.0
BIOEN,2024/12,4CAA,Düzeltmeler:,Adjustments:,48438008.0
BIOEN,2024/12,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,27440744.0
BIOEN,2024/12,4CAC,Karşılıklardaki Değişim,Change in Provisions,-397843.0
BIOEN,2024/12,4CAD,Diğer Gelir/ Gider,Other Income / Expense,19094876.0
BIOEN,2024/12,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),52199976.0
BIOEN,2024/12,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,1676736.0
BIOEN,2024/12,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),53876712.0
BIOEN,2024/12,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-3359741.0
BIOEN,2024/12,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-26411294.0
BIOEN,2024/12,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,487748.0
BIOEN,2024/12,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-25923546.0
BIOEN,2024/12,4CB,Serbest Nakit Akım,Free Cash Flow,24593424.0
BIOEN,2024/12,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,-26460237.0
BIOEN,2024/12,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2024/12,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2024/12,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,11918.0
BIOEN,2024/12,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,-26448319.0
BIOEN,2024/12,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,-1854894.0
BIOEN,2024/12,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2024/12,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2024/12,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,-1854894.0
BIOEN,2024/12,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2024/12,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,8108108.0
BIOEN,2024/12,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,3760964.0
BIOEN,2024/3,1A,Dönen Varlıklar,CURRENT ASSETS,36524002.0
BIOEN,2024/3,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,3567064.0
BIOEN,2024/3,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2024/3,1AC,Ticari Alacaklar,Short-Term Trade Receivables,7930670.0
BIOEN,2024/3,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2024/3,1AE,Diğer Alacaklar,Short-Term Other Receivables,259240.0
BIOEN,2024/3,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2024/3,1AF,Stoklar,Inventories,12504437.0
BIOEN,2024/3,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2024/3,1AH,Diğer Dönen Varlıklar,Other Current Assets,12262591.0
BIOEN,2024/3,1AI,(Ara Toplam),(Subtotal),36524002.0
BIOEN,2024/3,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2024/3,1AK,Duran Varlıklar,LONG TERM ASSETS,211112960.0
BIOEN,2024/3,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2024/3,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2024/3,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2024/3,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2024/3,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2024/3,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,13007988.0
BIOEN,2024/3,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2024/3,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,1234607.0
BIOEN,2024/3,1BFA,Stoklar,Stoklar,0.0
BIOEN,2024/3,1BFAA,Kullanım Hakkı Varlıkları,nan,4747018.0
BIOEN,2024/3,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,164313868.0
BIOEN,2024/3,1BGA,Şerefiye,Goodwill,1376577.0
BIOEN,2024/3,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,8460415.0
BIOEN,2024/3,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,17972488.0
BIOEN,2024/3,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2024/3,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,247636962.0
BIOEN,2024/3,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2024/3,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,75164300.0
BIOEN,2024/3,2AA,Finansal Borçlar,Short-Term Financial Loans,55658326.0
BIOEN,2024/3,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2024/3,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,14848112.0
BIOEN,2024/3,2AAGAB,Diğer Borçlar,Other Short-Term Loans,1969945.0
BIOEN,2024/3,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2024/3,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2024/3,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2024/3,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,499577.0
BIOEN,2024/3,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),0.0
BIOEN,2024/3,2AAGE,Borç Karşılıkları,Short-Term Provisions,648763.0
BIOEN,2024/3,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1539576.0
BIOEN,2024/3,2AAGG,(Ara Toplam),(Subtotal),75164300.0
BIOEN,2024/3,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2024/3,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,57254045.0
BIOEN,2024/3,2BA,Finansal Borçlar,Long-Term Financial Loans,56678213.0
BIOEN,2024/3,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2024/3,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2024/3,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2024/3,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2024/3,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2024/3,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2024/3,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2024/3,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,575832.0
BIOEN,2024/3,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2024/3,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2024/3,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2024/3,2N,Özkaynaklar,SHAREHOLDERS EQUITY,115218617.0
BIOEN,2024/3,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,114761418.0
BIOEN,2024/3,2OA,Ödenmiş Sermaye,Share Capital,15459009.0
BIOEN,2024/3,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2024/3,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,3750628.0
BIOEN,2024/3,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2024/3,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2024/3,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,696568.0
BIOEN,2024/3,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),67666956.0
BIOEN,2024/3,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),17241518.0
BIOEN,2024/3,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,9946740.0
BIOEN,2024/3,2ODA,Azınlık Payları,Minority Interests,457199.0
BIOEN,2024/3,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,247636962.0
BIOEN,2024/3,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2024/3,3C,Satış Gelirleri,Net Sales,26900439.0
BIOEN,2024/3,3CA,Satışların Maliyeti (-),Cost Of Sales,-23221865.0
BIOEN,2024/3,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2024/3,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,3678574.0
BIOEN,2024/3,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2024/3,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2024/3,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2024/3,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2024/3,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2024/3,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),3678574.0
BIOEN,2024/3,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-25199.0
BIOEN,2024/3,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-6057550.0
BIOEN,2024/3,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2024/3,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,766653.0
BIOEN,2024/3,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-381822.0
BIOEN,2024/3,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2024/3,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,-2019344.0
BIOEN,2024/3,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,-2404175.0
BIOEN,2024/3,3HA,Yatırım Faaliyetlerinden Gelirler,nan,0.0
BIOEN,2024/3,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-67913.0
BIOEN,2024/3,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2024/3,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,3972673.0
BIOEN,2024/3,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,1885416.0
BIOEN,2024/3,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),429809.0
BIOEN,2024/3,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),7600954.0
BIOEN,2024/3,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,-67913.0
BIOEN,2024/3,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,9916180.0
BIOEN,2024/3,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,14997667.0
BIOEN,2024/3,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),0.0
BIOEN,2024/3,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,14997667.0
BIOEN,2024/3,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2024/3,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,24913847.0
BIOEN,2024/3,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2024/3,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2024/3,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,24913847.0
BIOEN,2024/3,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2024/3,3LB,Azınlık Payları,Minority Interests,38870.0
BIOEN,2024/3,3Z,Ana Ortaklık Payları,Parent Shares,24874978.0
BIOEN,2024/3,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2024/3,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2024/3,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2024/3,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2024/3,4B,Amortisman Giderleri,Depreciation & Amortization,8615456.0
BIOEN,2024/3,4BA,Kıdem Tazminatı,Severance Payments,182333.0
BIOEN,2024/3,4BB,Finansman Giderleri,Financial Expenses,7600954.0
BIOEN,2024/3,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2024/3,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2024/3,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-98423349.0
BIOEN,2024/3,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-98423349.0
BIOEN,2024/3,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-98423349.0
BIOEN,2024/3,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,15346349.0
BIOEN,2024/3,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,24913847.0
BIOEN,2024/3,4CAA,Düzeltmeler:,Adjustments:,-6034232.0
BIOEN,2024/3,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,8615456.0
BIOEN,2024/3,4CAC,Karşılıklardaki Değişim,Change in Provisions,260530.0
BIOEN,2024/3,4CAD,Diğer Gelir/ Gider,Other Income / Expense,-15933108.0
BIOEN,2024/3,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),18879616.0
BIOEN,2024/3,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-3515267.0
BIOEN,2024/3,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),15364349.0
BIOEN,2024/3,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-18000.0
BIOEN,2024/3,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-5306856.0
BIOEN,2024/3,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,-356530.0
BIOEN,2024/3,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-5663386.0
BIOEN,2024/3,4CB,Serbest Nakit Akım,Free Cash Flow,9682963.0
BIOEN,2024/3,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,-1633671.0
BIOEN,2024/3,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2024/3,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2024/3,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-9468297.0
BIOEN,2024/3,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,-11101968.0
BIOEN,2024/3,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,-1419006.0
BIOEN,2024/3,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2024/3,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2024/3,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,-1419006.0
BIOEN,2024/3,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2024/3,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,7554318.0
BIOEN,2024/3,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,5146335.0
BIOEN,2024/6,1A,Dönen Varlıklar,CURRENT ASSETS,44197274.0
BIOEN,2024/6,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,7687386.0
BIOEN,2024/6,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2024/6,1AC,Ticari Alacaklar,Short-Term Trade Receivables,10693698.0
BIOEN,2024/6,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2024/6,1AE,Diğer Alacaklar,Short-Term Other Receivables,449490.0
BIOEN,2024/6,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2024/6,1AF,Stoklar,Inventories,11046313.0
BIOEN,2024/6,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2024/6,1AH,Diğer Dönen Varlıklar,Other Current Assets,14320388.0
BIOEN,2024/6,1AI,(Ara Toplam),(Subtotal),44197274.0
BIOEN,2024/6,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2024/6,1AK,Duran Varlıklar,LONG TERM ASSETS,198708082.0
BIOEN,2024/6,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2024/6,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2024/6,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2024/6,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2024/6,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2024/6,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,9286083.0
BIOEN,2024/6,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2024/6,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,1262925.0
BIOEN,2024/6,1BFA,Stoklar,Stoklar,0.0
BIOEN,2024/6,1BFAA,Kullanım Hakkı Varlıkları,nan,6537146.0
BIOEN,2024/6,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,167383857.0
BIOEN,2024/6,1BGA,Şerefiye,Goodwill,1467695.0
BIOEN,2024/6,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,9251137.0
BIOEN,2024/6,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,3519239.0
BIOEN,2024/6,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2024/6,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,242905356.0
BIOEN,2024/6,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2024/6,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,73582809.0
BIOEN,2024/6,2AA,Finansal Borçlar,Short-Term Financial Loans,57559611.0
BIOEN,2024/6,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2024/6,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,11396629.0
BIOEN,2024/6,2AAGAB,Diğer Borçlar,Other Short-Term Loans,2083046.0
BIOEN,2024/6,2AAGAC,Müşteri Söz. Doğan Yük.,nan,367836.0
BIOEN,2024/6,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2024/6,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2024/6,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2024/6,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),75901.0
BIOEN,2024/6,2AAGE,Borç Karşılıkları,Short-Term Provisions,645079.0
BIOEN,2024/6,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1454706.0
BIOEN,2024/6,2AAGG,(Ara Toplam),(Subtotal),73582809.0
BIOEN,2024/6,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2024/6,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,60378184.0
BIOEN,2024/6,2BA,Finansal Borçlar,Long-Term Financial Loans,59837416.0
BIOEN,2024/6,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2024/6,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2024/6,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2024/6,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2024/6,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2024/6,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2024/6,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2024/6,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,540768.0
BIOEN,2024/6,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2024/6,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2024/6,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2024/6,2N,Özkaynaklar,SHAREHOLDERS EQUITY,108944363.0
BIOEN,2024/6,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,108363395.0
BIOEN,2024/6,2OA,Ödenmiş Sermaye,Share Capital,15204362.0
BIOEN,2024/6,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2024/6,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,3998889.0
BIOEN,2024/6,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2024/6,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2024/6,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,742675.0
BIOEN,2024/6,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),70776752.0
BIOEN,2024/6,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),4264717.0
BIOEN,2024/6,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,13376000.0
BIOEN,2024/6,2ODA,Azınlık Payları,Minority Interests,580968.0
BIOEN,2024/6,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,242905356.0
BIOEN,2024/6,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2024/6,3C,Satış Gelirleri,Net Sales,53284975.0
BIOEN,2024/6,3CA,Satışların Maliyeti (-),Cost Of Sales,-49587935.0
BIOEN,2024/6,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2024/6,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,3697039.0
BIOEN,2024/6,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2024/6,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2024/6,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2024/6,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2024/6,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2024/6,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),3697039.0
BIOEN,2024/6,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-121822.0
BIOEN,2024/6,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-10963799.0
BIOEN,2024/6,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2024/6,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,2536010.0
BIOEN,2024/6,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-2155125.0
BIOEN,2024/6,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2024/6,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,-7007696.0
BIOEN,2024/6,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,-7388581.0
BIOEN,2024/6,3HA,Yatırım Faaliyetlerinden Gelirler,nan,7242725.0
BIOEN,2024/6,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-45.0
BIOEN,2024/6,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2024/6,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,-1943213.0
BIOEN,2024/6,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,-1708230.0
BIOEN,2024/6,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),1356783.0
BIOEN,2024/6,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),9957832.0
BIOEN,2024/6,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,7242679.0
BIOEN,2024/6,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,9606385.0
BIOEN,2024/6,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-5358229.0
BIOEN,2024/6,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-106349.0
BIOEN,2024/6,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-5251880.0
BIOEN,2024/6,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2024/6,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,4248157.0
BIOEN,2024/6,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2024/6,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2024/6,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,4248157.0
BIOEN,2024/6,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2024/6,3LB,Azınlık Payları,Minority Interests,171668.0
BIOEN,2024/6,3Z,Ana Ortaklık Payları,Parent Shares,4076489.0
BIOEN,2024/6,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2024/6,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2024/6,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2024/6,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2024/6,4B,Amortisman Giderleri,Depreciation & Amortization,13353801.0
BIOEN,2024/6,4BA,Kıdem Tazminatı,Severance Payments,276194.0
BIOEN,2024/6,4BB,Finansman Giderleri,Financial Expenses,9957832.0
BIOEN,2024/6,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2024/6,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2024/6,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-78288635.0
BIOEN,2024/6,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-78288635.0
BIOEN,2024/6,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-78288635.0
BIOEN,2024/6,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,1565483.0
BIOEN,2024/6,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,4248157.0
BIOEN,2024/6,4CAA,Düzeltmeler:,Adjustments:,8810050.0
BIOEN,2024/6,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,13353801.0
BIOEN,2024/6,4CAC,Karşılıklardaki Değişim,Change in Provisions,605690.0
BIOEN,2024/6,4CAD,Diğer Gelir/ Gider,Other Income / Expense,21911775.0
BIOEN,2024/6,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),13058207.0
BIOEN,2024/6,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-11103925.0
BIOEN,2024/6,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),1954281.0
BIOEN,2024/6,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-388798.0
BIOEN,2024/6,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-11527034.0
BIOEN,2024/6,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,12117172.0
BIOEN,2024/6,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,590138.0
BIOEN,2024/6,4CB,Serbest Nakit Akım,Free Cash Flow,2155621.0
BIOEN,2024/6,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,14264721.0
BIOEN,2024/6,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2024/6,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2024/6,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-12381231.0
BIOEN,2024/6,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,1883490.0
BIOEN,2024/6,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,4039111.0
BIOEN,2024/6,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2024/6,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2024/6,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,4039111.0
BIOEN,2024/6,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2024/6,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,7840562.0
BIOEN,2024/6,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,10759174.0
BIOEN,2024/9,1A,Dönen Varlıklar,CURRENT ASSETS,32691020.0
BIOEN,2024/9,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,4676260.0
BIOEN,2024/9,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2024/9,1AC,Ticari Alacaklar,Short-Term Trade Receivables,5887831.0
BIOEN,2024/9,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2024/9,1AE,Diğer Alacaklar,Short-Term Other Receivables,508116.0
BIOEN,2024/9,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2024/9,1AF,Stoklar,Inventories,10711444.0
BIOEN,2024/9,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2024/9,1AH,Diğer Dönen Varlıklar,Other Current Assets,10907369.0
BIOEN,2024/9,1AI,(Ara Toplam),(Subtotal),32691020.0
BIOEN,2024/9,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2024/9,1AK,Duran Varlıklar,LONG TERM ASSETS,212251475.0
BIOEN,2024/9,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2024/9,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2024/9,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2024/9,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2024/9,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2024/9,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,10588799.0
BIOEN,2024/9,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2024/9,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,1323370.0
BIOEN,2024/9,1BFA,Stoklar,Stoklar,0.0
BIOEN,2024/9,1BFAA,Kullanım Hakkı Varlıkları,nan,5895303.0
BIOEN,2024/9,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,175934196.0
BIOEN,2024/9,1BGA,Şerefiye,Goodwill,1537941.0
BIOEN,2024/9,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,10727040.0
BIOEN,2024/9,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,6244827.0
BIOEN,2024/9,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2024/9,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,244942495.0
BIOEN,2024/9,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2024/9,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,71868301.0
BIOEN,2024/9,2AA,Finansal Borçlar,Short-Term Financial Loans,58277548.0
BIOEN,2024/9,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2024/9,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,5742086.0
BIOEN,2024/9,2AAGAB,Diğer Borçlar,Other Short-Term Loans,2812517.0
BIOEN,2024/9,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2024/9,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2024/9,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2024/9,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,3240925.0
BIOEN,2024/9,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),37498.0
BIOEN,2024/9,2AAGE,Borç Karşılıkları,Short-Term Provisions,610030.0
BIOEN,2024/9,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1147696.0
BIOEN,2024/9,2AAGG,(Ara Toplam),(Subtotal),71868301.0
BIOEN,2024/9,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2024/9,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,58589969.0
BIOEN,2024/9,2BA,Finansal Borçlar,Long-Term Financial Loans,57994944.0
BIOEN,2024/9,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2024/9,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2024/9,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2024/9,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2024/9,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2024/9,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2024/9,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2024/9,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,595025.0
BIOEN,2024/9,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2024/9,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2024/9,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2024/9,2N,Özkaynaklar,SHAREHOLDERS EQUITY,114484225.0
BIOEN,2024/9,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,114118157.0
BIOEN,2024/9,2OA,Ödenmiş Sermaye,Share Capital,14627368.0
BIOEN,2024/9,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2024/9,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,4190281.0
BIOEN,2024/9,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2024/9,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2024/9,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,778220.0
BIOEN,2024/9,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),73442271.0
BIOEN,2024/9,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),6569578.0
BIOEN,2024/9,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,14510438.0
BIOEN,2024/9,2ODA,Azınlık Payları,Minority Interests,366068.0
BIOEN,2024/9,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,244942495.0
BIOEN,2024/9,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2024/9,3C,Satış Gelirleri,Net Sales,80236414.0
BIOEN,2024/9,3CA,Satışların Maliyeti (-),Cost Of Sales,-76218755.0
BIOEN,2024/9,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2024/9,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,4017658.0
BIOEN,2024/9,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2024/9,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2024/9,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2024/9,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2024/9,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2024/9,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),4017658.0
BIOEN,2024/9,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-221929.0
BIOEN,2024/9,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-15702135.0
BIOEN,2024/9,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2024/9,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,5218464.0
BIOEN,2024/9,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-4209599.0
BIOEN,2024/9,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2024/9,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,-10897541.0
BIOEN,2024/9,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,-11906406.0
BIOEN,2024/9,3HA,Yatırım Faaliyetlerinden Gelirler,nan,9803237.0
BIOEN,2024/9,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-23789.0
BIOEN,2024/9,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2024/9,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,-808852.0
BIOEN,2024/9,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,-1926944.0
BIOEN,2024/9,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),1772465.0
BIOEN,2024/9,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),8577924.0
BIOEN,2024/9,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,9779448.0
BIOEN,2024/9,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,8423445.0
BIOEN,2024/9,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-2345995.0
BIOEN,2024/9,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-52928.0
BIOEN,2024/9,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-2293067.0
BIOEN,2024/9,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2024/9,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,6077450.0
BIOEN,2024/9,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2024/9,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2024/9,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,6077450.0
BIOEN,2024/9,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2024/9,3LB,Azınlık Payları,Minority Interests,-161791.0
BIOEN,2024/9,3Z,Ana Ortaklık Payları,Parent Shares,6239241.0
BIOEN,2024/9,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2024/9,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2024/9,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2024/9,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2024/9,4B,Amortisman Giderleri,Depreciation & Amortization,21038071.0
BIOEN,2024/9,4BA,Kıdem Tazminatı,Severance Payments,109145.0
BIOEN,2024/9,4BB,Finansman Giderleri,Financial Expenses,8577924.0
BIOEN,2024/9,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2024/9,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2024/9,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-109895955.0
BIOEN,2024/9,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-109895955.0
BIOEN,2024/9,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-109895955.0
BIOEN,2024/9,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,12642121.0
BIOEN,2024/9,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,6077450.0
BIOEN,2024/9,4CAA,Düzeltmeler:,Adjustments:,8621662.0
BIOEN,2024/9,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,21038071.0
BIOEN,2024/9,4CAC,Karşılıklardaki Değişim,Change in Provisions,428159.0
BIOEN,2024/9,4CAD,Diğer Gelir/ Gider,Other Income / Expense,25173615.0
BIOEN,2024/9,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),14699112.0
BIOEN,2024/9,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,-1332603.0
BIOEN,2024/9,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),13366508.0
BIOEN,2024/9,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-724387.0
BIOEN,2024/9,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-22601940.0
BIOEN,2024/9,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,13341625.0
BIOEN,2024/9,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-9260315.0
BIOEN,2024/9,4CB,Serbest Nakit Akım,Free Cash Flow,3381806.0
BIOEN,2024/9,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,14383278.0
BIOEN,2024/9,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2024/9,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2024/9,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-17747609.0
BIOEN,2024/9,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,-3364331.0
BIOEN,2024/9,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,17475.0
BIOEN,2024/9,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2024/9,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2024/9,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,17475.0
BIOEN,2024/9,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2024/9,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,8257113.0
BIOEN,2024/9,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,6600541.0
BIOEN,2025/3,1A,Dönen Varlıklar,CURRENT ASSETS,27925414.0
BIOEN,2025/3,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,1668768.0
BIOEN,2025/3,1AB,Finansal Yatırımlar,Short-Term Financial Investments,0.0
BIOEN,2025/3,1AC,Ticari Alacaklar,Short-Term Trade Receivables,5835188.0
BIOEN,2025/3,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2025/3,1AE,Diğer Alacaklar,Short-Term Other Receivables,1305465.0
BIOEN,2025/3,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2025/3,1AF,Stoklar,Inventories,9641355.0
BIOEN,2025/3,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2025/3,1AH,Diğer Dönen Varlıklar,Other Current Assets,9474638.0
BIOEN,2025/3,1AI,(Ara Toplam),(Subtotal),27925414.0
BIOEN,2025/3,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2025/3,1AK,Duran Varlıklar,LONG TERM ASSETS,214708401.0
BIOEN,2025/3,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2025/3,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2025/3,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2025/3,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2025/3,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2025/3,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,9450436.0
BIOEN,2025/3,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2025/3,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,520588.0
BIOEN,2025/3,1BFA,Stoklar,Stoklar,0.0
BIOEN,2025/3,1BFAA,Kullanım Hakkı Varlıkları,nan,5429452.0
BIOEN,2025/3,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,179844369.0
BIOEN,2025/3,1BGA,Şerefiye,Goodwill,1625233.0
BIOEN,2025/3,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,11498383.0
BIOEN,2025/3,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,6339941.0
BIOEN,2025/3,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2025/3,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,242633815.0
BIOEN,2025/3,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2025/3,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,49296750.0
BIOEN,2025/3,2AA,Finansal Borçlar,Short-Term Financial Loans,31236454.0
BIOEN,2025/3,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2025/3,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,10446405.0
BIOEN,2025/3,2AAGAB,Diğer Borçlar,Other Short-Term Loans,4931550.0
BIOEN,2025/3,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2025/3,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2025/3,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2025/3,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,307637.0
BIOEN,2025/3,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),85488.0
BIOEN,2025/3,2AAGE,Borç Karşılıkları,Short-Term Provisions,656636.0
BIOEN,2025/3,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1632580.0
BIOEN,2025/3,2AAGG,(Ara Toplam),(Subtotal),49296750.0
BIOEN,2025/3,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2025/3,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,84830170.0
BIOEN,2025/3,2BA,Finansal Borçlar,Long-Term Financial Loans,84110814.0
BIOEN,2025/3,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2025/3,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2025/3,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2025/3,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2025/3,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2025/3,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2025/3,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2025/3,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,0.0
BIOEN,2025/3,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2025/3,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,0.0
BIOEN,2025/3,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,719356.0
BIOEN,2025/3,2N,Özkaynaklar,SHAREHOLDERS EQUITY,108506896.0
BIOEN,2025/3,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,108506896.0
BIOEN,2025/3,2OA,Ödenmiş Sermaye,Share Capital,13215731.0
BIOEN,2025/3,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2025/3,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,4428119.0
BIOEN,2025/3,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2025/3,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2025/3,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,822391.0
BIOEN,2025/3,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),80552052.0
BIOEN,2025/3,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),-6990520.0
BIOEN,2025/3,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,16479123.0
BIOEN,2025/3,2ODA,Azınlık Payları,Minority Interests,0.0
BIOEN,2025/3,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,242633815.0
BIOEN,2025/3,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2025/3,3C,Satış Gelirleri,Net Sales,17720876.0
BIOEN,2025/3,3CA,Satışların Maliyeti (-),Cost Of Sales,-16969137.0
BIOEN,2025/3,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2025/3,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,751739.0
BIOEN,2025/3,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2025/3,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2025/3,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2025/3,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2025/3,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2025/3,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),751739.0
BIOEN,2025/3,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-27902.0
BIOEN,2025/3,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-3877248.0
BIOEN,2025/3,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2025/3,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,576600.0
BIOEN,2025/3,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-248528.0
BIOEN,2025/3,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2025/3,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,-2825338.0
BIOEN,2025/3,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,-3153410.0
BIOEN,2025/3,3HA,Yatırım Faaliyetlerinden Gelirler,nan,7761.0
BIOEN,2025/3,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-41796.0
BIOEN,2025/3,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2025/3,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,180132.0
BIOEN,2025/3,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,-2679242.0
BIOEN,2025/3,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),193708.0
BIOEN,2025/3,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-3177711.0
BIOEN,2025/3,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,-34035.0
BIOEN,2025/3,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,-5663244.0
BIOEN,2025/3,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,-1631533.0
BIOEN,2025/3,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-89209.0
BIOEN,2025/3,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,-1542325.0
BIOEN,2025/3,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2025/3,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,-7294778.0
BIOEN,2025/3,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2025/3,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2025/3,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,-7294778.0
BIOEN,2025/3,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2025/3,3LB,Azınlık Payları,Minority Interests,0.0
BIOEN,2025/3,3Z,Ana Ortaklık Payları,Parent Shares,-7294778.0
BIOEN,2025/3,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2025/3,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2025/3,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2025/3,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2025/3,4B,Amortisman Giderleri,Depreciation & Amortization,5422723.0
BIOEN,2025/3,4BA,Kıdem Tazminatı,Severance Payments,214725.0
BIOEN,2025/3,4BB,Finansman Giderleri,Financial Expenses,-3177711.0
BIOEN,2025/3,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2025/3,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2025/3,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-112688595.0
BIOEN,2025/3,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-112688595.0
BIOEN,2025/3,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-112688595.0
BIOEN,2025/3,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,4896937.0
BIOEN,2025/3,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,-7294778.0
BIOEN,2025/3,4CAA,Düzeltmeler:,Adjustments:,8539352.0
BIOEN,2025/3,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,5422723.0
BIOEN,2025/3,4CAC,Karşılıklardaki Değişim,Change in Provisions,88845.0
BIOEN,2025/3,4CAD,Diğer Gelir/ Gider,Other Income / Expense,2754206.0
BIOEN,2025/3,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),1244574.0
BIOEN,2025/3,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,3692535.0
BIOEN,2025/3,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),4937109.0
BIOEN,2025/3,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-40173.0
BIOEN,2025/3,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-2757313.0
BIOEN,2025/3,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,0.0
BIOEN,2025/3,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-2757313.0
BIOEN,2025/3,4CB,Serbest Nakit Akım,Free Cash Flow,2139624.0
BIOEN,2025/3,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,-202903.0
BIOEN,2025/3,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2025/3,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2025/3,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-2914045.0
BIOEN,2025/3,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,-3116948.0
BIOEN,2025/3,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,-977324.0
BIOEN,2025/3,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2025/3,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2025/3,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,-977324.0
BIOEN,2025/3,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2025/3,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,2992303.0
BIOEN,2025/3,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,1741400.0
BIOEN,2025/6,1A,Dönen Varlıklar,CURRENT ASSETS,24474492.0
BIOEN,2025/6,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,758233.0
BIOEN,2025/6,1AB,Finansal Yatırımlar,Short-Term Financial Investments,577075.0
BIOEN,2025/6,1AC,Ticari Alacaklar,Short-Term Trade Receivables,4424854.0
BIOEN,2025/6,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2025/6,1AE,Diğer Alacaklar,Short-Term Other Receivables,1712864.0
BIOEN,2025/6,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2025/6,1AF,Stoklar,Inventories,8701014.0
BIOEN,2025/6,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2025/6,1AH,Diğer Dönen Varlıklar,Other Current Assets,8300452.0
BIOEN,2025/6,1AI,(Ara Toplam),(Subtotal),24474492.0
BIOEN,2025/6,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2025/6,1AK,Duran Varlıklar,LONG TERM ASSETS,222178743.0
BIOEN,2025/6,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2025/6,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2025/6,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2025/6,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2025/6,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2025/6,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,9561084.0
BIOEN,2025/6,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2025/6,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,524431.0
BIOEN,2025/6,1BFA,Stoklar,Stoklar,0.0
BIOEN,2025/6,1BFAA,Kullanım Hakkı Varlıkları,nan,4887877.0
BIOEN,2025/6,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,179050570.0
BIOEN,2025/6,1BGA,Şerefiye,Goodwill,1637229.0
BIOEN,2025/6,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,11275724.0
BIOEN,2025/6,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,15241829.0
BIOEN,2025/6,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2025/6,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,246653235.0
BIOEN,2025/6,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2025/6,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,46208242.0
BIOEN,2025/6,2AA,Finansal Borçlar,Short-Term Financial Loans,31388675.0
BIOEN,2025/6,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2025/6,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,8732915.0
BIOEN,2025/6,2AAGAB,Diğer Borçlar,Other Short-Term Loans,3778377.0
BIOEN,2025/6,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2025/6,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2025/6,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2025/6,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,424450.0
BIOEN,2025/6,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),0.0
BIOEN,2025/6,2AAGE,Borç Karşılıkları,Short-Term Provisions,544502.0
BIOEN,2025/6,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1339324.0
BIOEN,2025/6,2AAGG,(Ara Toplam),(Subtotal),46208242.0
BIOEN,2025/6,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2025/6,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,96321872.0
BIOEN,2025/6,2BA,Finansal Borçlar,Long-Term Financial Loans,88487956.0
BIOEN,2025/6,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2025/6,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2025/6,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2025/6,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2025/6,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2025/6,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2025/6,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2025/6,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,462571.0
BIOEN,2025/6,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2025/6,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,7371345.0
BIOEN,2025/6,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2025/6,2N,Özkaynaklar,SHAREHOLDERS EQUITY,104123122.0
BIOEN,2025/6,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,104123122.0
BIOEN,2025/6,2OA,Ödenmiş Sermaye,Share Capital,12558901.0
BIOEN,2025/6,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2025/6,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,4460804.0
BIOEN,2025/6,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2025/6,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2025/6,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,1224273.0
BIOEN,2025/6,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),81464759.0
BIOEN,2025/6,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),-12924573.0
BIOEN,2025/6,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,17338958.0
BIOEN,2025/6,2ODA,Azınlık Payları,Minority Interests,0.0
BIOEN,2025/6,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,246653235.0
BIOEN,2025/6,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2025/6,3C,Satış Gelirleri,Net Sales,36139220.0
BIOEN,2025/6,3CA,Satışların Maliyeti (-),Cost Of Sales,-34362777.0
BIOEN,2025/6,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2025/6,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,1776443.0
BIOEN,2025/6,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2025/6,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2025/6,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2025/6,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2025/6,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2025/6,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),1776443.0
BIOEN,2025/6,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-65396.0
BIOEN,2025/6,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-7745458.0
BIOEN,2025/6,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2025/6,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,811789.0
BIOEN,2025/6,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-625432.0
BIOEN,2025/6,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2025/6,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,-5848053.0
BIOEN,2025/6,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,-6034411.0
BIOEN,2025/6,3HA,Yatırım Faaliyetlerinden Gelirler,nan,441389.0
BIOEN,2025/6,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-42855.0
BIOEN,2025/6,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2025/6,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,228128.0
BIOEN,2025/6,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,-5221392.0
BIOEN,2025/6,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),221693.0
BIOEN,2025/6,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-8752939.0
BIOEN,2025/6,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,398534.0
BIOEN,2025/6,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,-13752637.0
BIOEN,2025/6,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,25124.0
BIOEN,2025/6,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),0.0
BIOEN,2025/6,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,25124.0
BIOEN,2025/6,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2025/6,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,-13727513.0
BIOEN,2025/6,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2025/6,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2025/6,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,-13727513.0
BIOEN,2025/6,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2025/6,3LB,Azınlık Payları,Minority Interests,0.0
BIOEN,2025/6,3Z,Ana Ortaklık Payları,Parent Shares,-13727513.0
BIOEN,2025/6,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2025/6,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2025/6,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2025/6,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2025/6,4B,Amortisman Giderleri,Depreciation & Amortization,11113198.0
BIOEN,2025/6,4BA,Kıdem Tazminatı,Severance Payments,156233.0
BIOEN,2025/6,4BB,Finansman Giderleri,Financial Expenses,-8752939.0
BIOEN,2025/6,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2025/6,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2025/6,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-119009966.0
BIOEN,2025/6,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-123728612.0
BIOEN,2025/6,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-119009966.0
BIOEN,2025/6,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,6503331.0
BIOEN,2025/6,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,-13727513.0
BIOEN,2025/6,4CAA,Düzeltmeler:,Adjustments:,16428308.0
BIOEN,2025/6,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,11113198.0
BIOEN,2025/6,4CAC,Karşılıklardaki Değişim,Change in Provisions,253473.0
BIOEN,2025/6,4CAD,Diğer Gelir/ Gider,Other Income / Expense,20479727.0
BIOEN,2025/6,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),2700795.0
BIOEN,2025/6,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,3872928.0
BIOEN,2025/6,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),6573723.0
BIOEN,2025/6,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-70392.0
BIOEN,2025/6,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-4751597.0
BIOEN,2025/6,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,0.0
BIOEN,2025/6,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-4751597.0
BIOEN,2025/6,4CB,Serbest Nakit Akım,Free Cash Flow,1751733.0
BIOEN,2025/6,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,3264727.0
BIOEN,2025/6,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2025/6,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2025/6,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-6828545.0
BIOEN,2025/6,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,-3563817.0
BIOEN,2025/6,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,-1812084.0
BIOEN,2025/6,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2025/6,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2025/6,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,-1812084.0
BIOEN,2025/6,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2025/6,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,3030125.0
BIOEN,2025/6,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,779574.0
BIOEN,2025/9,1A,Dönen Varlıklar,CURRENT ASSETS,23313780.0
BIOEN,2025/9,1AA,Nakit ve Nakit Benzerleri,Cash and Cash Equivalents,1392279.0
BIOEN,2025/9,1AB,Finansal Yatırımlar,Short-Term Financial Investments,586773.0
BIOEN,2025/9,1AC,Ticari Alacaklar,Short-Term Trade Receivables,4638424.0
BIOEN,2025/9,1AD,Finans Sektörü Faaliyetlerinden Alacaklar,Short-Term Receivables from Financial Operations,0.0
BIOEN,2025/9,1AE,Diğer Alacaklar,Short-Term Other Receivables,1212426.0
BIOEN,2025/9,1AEA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2025/9,1AF,Stoklar,Inventories,7712322.0
BIOEN,2025/9,1AG,Canlı Varlıklar,Short-Term Live Assets,0.0
BIOEN,2025/9,1AH,Diğer Dönen Varlıklar,Other Current Assets,7771558.0
BIOEN,2025/9,1AI,(Ara Toplam),(Subtotal),23313780.0
BIOEN,2025/9,1AJ,Satış Amacıyla Elde Tutulan Duran Varlıklar,Assets to be Sold,0.0
BIOEN,2025/9,1AK,Duran Varlıklar,LONG TERM ASSETS,227987589.0
BIOEN,2025/9,1B,Ticari Alacaklar,Trade Receivables,0.0
BIOEN,2025/9,1BA,Finans Sektörü Faaliyetlerinden Alacaklar,Long-Term Receivables from Financial Operations,0.0
BIOEN,2025/9,1BB,Diğer Alacaklar,Other Receivables,0.0
BIOEN,2025/9,1BBA,Müşteri Sözleşmelerinden Doğan Varlıklar,nan,0.0
BIOEN,2025/9,1BC,Finansal Yatırımlar,Financial Investments,0.0
BIOEN,2025/9,1BD,Özkaynak Yöntemiyle Değerlenen Yatırımlar,Investments with Equity Method,10308660.0
BIOEN,2025/9,1BE,Canlı Varlıklar,Long-Term Live Assets,0.0
BIOEN,2025/9,1BF,Yatırım Amaçlı Gayrimenkuller,Real Estate Investments,539798.0
BIOEN,2025/9,1BFA,Stoklar,Stoklar,0.0
BIOEN,2025/9,1BFAA,Kullanım Hakkı Varlıkları,nan,4462978.0
BIOEN,2025/9,1BG,Maddi Duran Varlıklar,Tangible Fixed Assets,185410381.0
BIOEN,2025/9,1BGA,Şerefiye,Goodwill,1685205.0
BIOEN,2025/9,1BH,Maddi Olmayan Duran Varlıklar,Intangible Fixed Assets,11287548.0
BIOEN,2025/9,1BJ,Ertelenmiş Vergi Varlığı,Long Term Deffered Tax Assets,14293020.0
BIOEN,2025/9,1BK,Diğer Duran Varlıklar,Other Long-Term Assets,0.0
BIOEN,2025/9,1BL,TOPLAM VARLIKLAR,TOTAL ASSETS,251301370.0
BIOEN,2025/9,1BM,KAYNAKLAR,LIABILITIES,0.0
BIOEN,2025/9,2A,Kısa Vadeli Yükümlülükler,SHORT TERM LIABILITIES,51089556.0
BIOEN,2025/9,2AA,Finansal Borçlar,Short-Term Financial Loans,32661096.0
BIOEN,2025/9,2AAG,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2025/9,2AAGAA,Ticari Borçlar,Short-Term Trade Payables,12750629.0
BIOEN,2025/9,2AAGAB,Diğer Borçlar,Other Short-Term Loans,3671530.0
BIOEN,2025/9,2AAGAC,Müşteri Söz. Doğan Yük.,nan,0.0
BIOEN,2025/9,2AAGB,Finans Sektörü Faaliyetlerinden Borçlar,Short-Term Loans from Financial Operations,0.0
BIOEN,2025/9,2AAGC,Devlet Teşvik ve Yardımları,Short-Term Government Promotions and Aids,0.0
BIOEN,2025/9,2AAGCA,Ertelenmiş Gelirler (Müşteri Söz. Doğan Yük. Dış.Kal.),nan,173532.0
BIOEN,2025/9,2AAGD,Dönem Karı Vergi Yükümlülüğü,Taxation Liabilities on Income (-),47230.0
BIOEN,2025/9,2AAGE,Borç Karşılıkları,Short-Term Provisions,512836.0
BIOEN,2025/9,2AAGF,Diğer Kısa Vadeli Yükümlülükler,Other Short-Term Liabilities,1272705.0
BIOEN,2025/9,2AAGG,(Ara Toplam),(Subtotal),51089556.0
BIOEN,2025/9,2AAGH,Satış Amaçlı Elde Tutulan Duran Varlıklara İlişkin Yükümlülükler,Liabilities on Assets to be Sold,0.0
BIOEN,2025/9,2B,Uzun Vadeli Yükümlülükler,LONG TERM LIABILITIES,95666263.0
BIOEN,2025/9,2BA,Finansal Borçlar,Long-Term Financial Loans,89121046.0
BIOEN,2025/9,2BB,Diğer Finansal Yükümlülükler,Other Short-Term Financial Liabilities,0.0
BIOEN,2025/9,2BBA,Ticari Borçlar,Long-Term Trade Payables,0.0
BIOEN,2025/9,2BBB,Diğer Borçlar,Other Long-Term Loans,0.0
BIOEN,2025/9,2BBBA,Müşteri Söz.Doğan Yük.,nan,0.0
BIOEN,2025/9,2BC,Finans Sektörü Faaliyetlerinden Borçlar,Long-Term Loans from Financial Operations,0.0
BIOEN,2025/9,2BD,Devlet Teşvik ve Yardımları,Long-Term Government Promotions and Aids,0.0
BIOEN,2025/9,2BDA,Ertelenmiş Gelirler (Müşteri Söz.Doğan Yük. Dış.Kal.),nan,0.0
BIOEN,2025/9,2BE,Uzun vadeli karşılıklar,Long-Term Provisions,458175.0
BIOEN,2025/9,2BF,Çalışanlara Sağlanan Faydalara İliş.Karş.,Provisions for Retirment Pay,0.0
BIOEN,2025/9,2BG,Ertelenmiş Vergi Yükümlülüğü,Deferred Tax Liabilities,6087042.0
BIOEN,2025/9,2BH,Diğer Uzun Vadeli Yükümlülükler,Other Long-Term Liabilities,0.0
BIOEN,2025/9,2N,Özkaynaklar,SHAREHOLDERS EQUITY,104545550.0
BIOEN,2025/9,2O,Ana Ortaklığa Ait Özkaynaklar,Parent Shareholders Capital,104545550.0
BIOEN,2025/9,2OA,Ödenmiş Sermaye,Share Capital,12024549.0
BIOEN,2025/9,2OC,Karşılıklı İştirak Sermayesi Düzeltmesi (-),Adjustments to Share Capital,0.0
BIOEN,2025/9,2OCA,Hisse Senedi İhraç Primleri,Premium in Excess of Par,4591519.0
BIOEN,2025/9,2OCB,Değer Artış Fonları,Market Value Surpluses,0.0
BIOEN,2025/9,2OCC,Yabancı Para Çevrim Farkları,FX Translation Differences,0.0
BIOEN,2025/9,2OCD,Kardan Ayrılan Kısıtlanmış Yedekler,Income Reserves,1260149.0
BIOEN,2025/9,2OCE,Geçmiş Yıllar Kar/Zararları,Retained Earnings /(Acc. Losses),83851938.0
BIOEN,2025/9,2OCF,Dönem Net Kar/Zararı,Current Year Income /(Losses),-16399472.0
BIOEN,2025/9,2OD,Diğer Özsermaye Kalemleri,Other Sholders Equity Items,19216867.0
BIOEN,2025/9,2ODA,Azınlık Payları,Minority Interests,0.0
BIOEN,2025/9,2ODB,TOPLAM KAYNAKLAR,TOTAL LIABILITIES AND S.HOLDERS EQUITY,251301370.0
BIOEN,2025/9,3B,Sürdürülen Faaliyetler,Continuing Operations,0.0
BIOEN,2025/9,3C,Satış Gelirleri,Net Sales,55266341.0
BIOEN,2025/9,3CA,Satışların Maliyeti (-),Cost Of Sales,-53016199.0
BIOEN,2025/9,3CAA,Ticari Faaliyetlerden Diğer Kar (Zarar),Other Profit (Loss) from Trade Operations,0.0
BIOEN,2025/9,3CAB,Ticari Faaliyetlerden Brüt Kar (Zarar),Gross Profit (Loss) from Trade Operations,2250143.0
BIOEN,2025/9,3CAC,"Faiz, Ücret, Prim, Komisyon ve Diğer Gelirler","Proceeds from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2025/9,3CAD,"Faiz, Ücret, Prim, Komisyon ve Diğer Giderler (-)","Expenses from Interest, Fee, Premium, Commission and Other",0.0
BIOEN,2025/9,3CAE,Finans Sektörü Faaliyetlerinden Diğer Kar (Zarar),Other Profit (Loss) from Financial Operations,0.0
BIOEN,2025/9,3CAF,Finans Sektörü Faaliyetlerinden Brüt Kar (Zarar),Gross Profit (Loss) from Financial Operations,0.0
BIOEN,2025/9,3CB,Diğer Gelir ve Giderler,Other Income (Expenses),0.0
BIOEN,2025/9,3D,BRÜT KAR (ZARAR),GROSS PROFIT (LOSS),2250143.0
BIOEN,2025/9,3DA,"Pazarlama, Satış ve Dağıtım Giderleri (-)",Marketing Selling & Distrib. Expenses (-),-96377.0
BIOEN,2025/9,3DB,Genel Yönetim Giderleri (-),General Administrative Expenses (-),-11913882.0
BIOEN,2025/9,3DC,Araştırma ve Geliştirme Giderleri (-),Research & Development Expenses (-),0.0
BIOEN,2025/9,3DD,Diğer Faaliyet Gelirleri,Income from Other Operations,1107502.0
BIOEN,2025/9,3DE,Diğer Faaliyet Giderleri (-),Expenses from Other Operations (-),-1413061.0
BIOEN,2025/9,3DEA,Faaliyet Karı Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Operating Profits,0.0
BIOEN,2025/9,3DF,FAALİYET KARI (ZARARI),OPERATING PROFITS,-10065675.0
BIOEN,2025/9,3H,Net Faaliyet Kar/Zararı,Net Operating Profits,-9760116.0
BIOEN,2025/9,3HA,Yatırım Faaliyetlerinden Gelirler,nan,491430.0
BIOEN,2025/9,3HAA,Yatırım Faaliyetlerinden Giderler (-),nan,-45456.0
BIOEN,2025/9,3HAB,Diğer Gelir ve Giderler,nan,0.0
BIOEN,2025/9,3HAC,Özkaynak Yöntemiyle Değerlenen Yatırımların Kar/Zararlarındaki Paylar,Profit (Loss) from Subsidiaries,740951.0
BIOEN,2025/9,3HACA,Finansman Gideri Öncesi Faaliyet Karı/Zararı,nan,-8878750.0
BIOEN,2025/9,3HB,(Esas Faaliyet Dışı) Finansal Gelirler,Financial Income (from Other Operations),416160.0
BIOEN,2025/9,3HC,(Esas Faaliyet Dışı) Finansal Giderler (-),Financial Expenses (from Other Operations) (-),-9449748.0
BIOEN,2025/9,3HCA,Vergi Öncesi Diğer Gelir ve Giderler,Other Income (Expenses) Before Tax,445974.0
BIOEN,2025/9,3I,SÜRDÜRÜLEN FAALİYETLER VERGİ ÖNCESİ KARI (ZARARI),PROFIT BEFORE TAX FROM CONTINUING OPERATIONS,-17912338.0
BIOEN,2025/9,3IA,Sürdürülen Faaliyetler Vergi Geliri (Gideri),Taxation on Continuing Operations,263112.0
BIOEN,2025/9,3IB,Dönem Vergi Geliri (Gideri),Taxation on Income (Expenses),-50829.0
BIOEN,2025/9,3IC,Ertelenmiş Vergi Geliri (Gideri),Income (Expenses) of Deferred Tax,313941.0
BIOEN,2025/9,3ID,Diğer Vergi Geliri (Gideri),Other Taxation Income (Expenses),0.0
BIOEN,2025/9,3J,SÜRDÜRÜLEN FAALİYETLER DÖNEM KARI/ZARARI,PROFIT FROM CONTINUING OPERATIONS,-17649226.0
BIOEN,2025/9,3K,DURDURULAN FAALİYETLER,DISCONTINUED OPERATIONS,0.0
BIOEN,2025/9,3KA,Durdurulan Faaliyetler Vergi Sonrası Dönem Karı (Zararı),Profit After Taxes from Discontinued Operations,0.0
BIOEN,2025/9,3L,DÖNEM KARI (ZARARI),NET PROFIT AFTER TAXES,-17649226.0
BIOEN,2025/9,3LA,Dönem Kar/Zararının Dağılımı,Distrubition of Profit (Loss),0.0
BIOEN,2025/9,3LB,Azınlık Payları,Minority Interests,0.0
BIOEN,2025/9,3Z,Ana Ortaklık Payları,Parent Shares,-17649226.0
BIOEN,2025/9,3ZD,Hisse Başına Kazanç,Earnings per Share,0.0
BIOEN,2025/9,3ZE,Seyreltilmiş Hisse Başına Kazanç,Diluted Earnings per Share,0.0
BIOEN,2025/9,3ZF,Sürdürülen Faaliyetlerden Hisse Başına Kazanç,Earnings per Share from Continuing Operations,0.0
BIOEN,2025/9,3ZG,Sürdürülen Faaliyetlerden Seyreltilmiş Hisse Başına Kazanç,Earnings per Share from Discontinued Operations,0.0
BIOEN,2025/9,4B,Amortisman Giderleri,Depreciation & Amortization,17409608.0
BIOEN,2025/9,4BA,Kıdem Tazminatı,Severance Payments,90904.0
BIOEN,2025/9,4BB,Finansman Giderleri,Financial Expenses,-9449748.0
BIOEN,2025/9,4BC,Yurtiçi Satışlar,Domestic Sales,0.0
BIOEN,2025/9,4BD,Yurtdışı Satışlar,Export Sales,0.0
BIOEN,2025/9,4BE,Net Yabancı Para Pozisyonu,Net Fx Position,-125964288.0
BIOEN,2025/9,4BEA,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,Parasal net yabancı para varlık/(yükümlülük) pozisyonu,-129288097.0
BIOEN,2025/9,4BEB,Net YPP (Hedge Dahil),Net YPP (Hedge Dahil),-125964288.0
BIOEN,2025/9,4C,İşletme Faaliyetlerinden Kaynaklanan Net Nakit,Net Cash from Operations,14475890.0
BIOEN,2025/9,4CA,Düzeltme Öncesi Kar,Earnings Before Adjustments,-17649226.0
BIOEN,2025/9,4CAA,Düzeltmeler:,Adjustments:,22136882.0
BIOEN,2025/9,4CAB,Amortisman & İtfa Payları,Depreciation & Amortisation,17409608.0
BIOEN,2025/9,4CAC,Karşılıklardaki Değişim,Change in Provisions,258162.0
BIOEN,2025/9,4CAD,Diğer Gelir/ Gider,Other Income / Expense,27834313.0
BIOEN,2025/9,4CAE,İşletme Sermayesinde Değişikler Öncesi Faaliyet Karı (+),Operating Profit Before Changes in Working Capital (+),4487657.0
BIOEN,2025/9,4CAF,İşletme Sermayesindeki Değişiklikler,Change in Working Capital,10211799.0
BIOEN,2025/9,4CAG,Esas Faaliyet ile İlgili Oluşan Nakit (+),Cash from Core Operations (+),14699456.0
BIOEN,2025/9,4CAH,Diğer İşletme Faaliyetlerinden Nakit,Cash from Other Operations,-223566.0
BIOEN,2025/9,4CAI,Sabit Sermaye Yatırımları,Capital Expenditures (CapEx),-10902399.0
BIOEN,2025/9,4CAJ,Diğer Yatırım Faaliyetlerinden Nakit,Cash from Other Investment Operations,0.0
BIOEN,2025/9,4CAK,Yatırım Faaliyetlerinden Kaynaklanan Nakit,Cash from Investment Operations,-10902399.0
BIOEN,2025/9,4CB,Serbest Nakit Akım,Free Cash Flow,3573490.0
BIOEN,2025/9,4CBA,Finansal Borçlardaki Değişim,Change in Financial Debt,6289269.0
BIOEN,2025/9,4CBB,Temettü Ödemeleri,Dividends Paid,0.0
BIOEN,2025/9,4CBC,Sermaye Artırımı,Rights Issue,0.0
BIOEN,2025/9,4CBD,Diğer Finansman Faaliyetlerinden Nakit,Cash from Other Financial Operations,-10983938.0
BIOEN,2025/9,4CBE,Finansman Faaliyetlerden Kaynaklanan Nakit,Cash from Financial Operations,-4694669.0
BIOEN,2025/9,4CBF,Yab. Para Çev. Fark. Etk. Önc.Nak.Ve Nak. Benz. Net Artış/Azalış,Cash Net Inc. / Dec. before For.Cur. Trans. Dif.,-1121178.0
BIOEN,2025/9,4CBG,Yab.ı Para Çevrim Fark. Nakit Ve Nakit Benz. Üzerindeki Etkisi,Foreign Curr. Trans.Diff.Cash and Cash Benz. Imp.,0.0
BIOEN,2025/9,4CBH,Diğer Nakit Girişi/Çıkışı,Other Cash Inflow/Outflow,0.0
BIOEN,2025/9,4CBI,Nakit ve Benzerlerindeki Değişim,Change in Cash & Cash Equivalents,-1121178.0
BIOEN,2025/9,4CBJ,Diğer Nakit ve Nakit Benzerlerindeki Artış,Other Cash & Cash Equivalents Change,0.0
BIOEN,2025/9,4CBK,Dönem Başı Nakit Değerler,Cash at the beginning of the Quarter,3199897.0
BIOEN,2025/9,4CBL,Dönem Sonu Nakit,Cash at the End of the Quarter,1429972.0
